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ABSTRACT 
 
 
The translation of mRNA into functional proteins is essential for all life.  In 
eukaryotes, aberrant RNAs containing sequence features that stall or severely 
slow down ribosomes are subject to translation-dependent quality control.  
Targets include mRNAs encoding a strong secondary structure (No-Go Decay; 
NGD) or stretches of positively-charged amino acids (Peptide-dependent 
Translation Arrest/Ribosome Quality Control; PDTA/RQC), mRNAs lacking an in-
frame stop codon (Non-Stop Decay; NSD), or defective 18S rRNAs (18S 
Nonfunctional rRNA Decay; 18S NRD).  Previous work from our lab showed that 
the S. cerevisiae NGD factors DOM34 and HBS1, and PDTA/RQC factor ASC1, 
all participate in the kinetics of 18S NRD.  Upon further investigation of 18S NRD, 
our research revealed the critical role of ribosomal protein S3 (RPS3), thus 
adding to the emerging evidence that the ribosome senses its own translational 
status.   
While aberrant mRNAs mentioned above can occur endogenously, 
damaging agents, such as oxidative stress or UV irradiation, can negatively 
affect the chemical integrity of RNA.  Such lesions could lead to translation errors 
and ribosome stalling.  However, current tools to monitor the fate of damaged 
RNA are quite limited and only provide a low-resolution picture.  Therefore, we 
sought to develop a deep-sequencing method to detect damaged RNA, taking 
  
viii	
advantage of reverse transcriptase's ability to insert a mutation across a 
damaged site.  Using oxidized RNA as a model damaged RNA, our preliminary 
data showed increased G>T mutations in oxidized RNA.  This method provides 
the foundation for future work aimed at understanding how cells deal with 
damaged RNA. 
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CHAPTER I.  INTRODUCTION 
 
Translation-dependent quality control 
 
Precise and efficient flow of genetic information is essential for all life.  
Sequence information encoded in deoxyribonucleic acid (DNA) is transcribed and 
processed into ribonucleic acid (RNA), which then serve as either functional 
molecules – such as ribosomal RNA (rRNA) and transfer RNA (tRNA) – or 
become templates for protein translation (messenger RNA; mRNA).  The 
translation of mRNA into protein is a multistep process coordinated by a myriad 
of associated factors.  At the core of translation is the highly conserved, 
ribonucleoprotein complex known as the ribosome.  In eukaryotes, the ribosome 
consists of a small (40S) and large (60S) subunit that join together to form 
translationally competent 80S particles.  Translation can be divided into four 
distinct steps: 1) initiation; 2) elongation; 3) termination; and 4) recycling.  
Translation initiation commences with the assembly of the 40S subunit, initiator 
methionyl-tRNA (Met-tRNAi) positioned at the P-site, and eukaryotic initiation 
factors to form the pre-initiation complex (PIC).  The PIC binds to the 5' end of 
the mRNA and proceeds to scan the mRNA until it encounters a start codon 
(Aitken and Lorsch 2012).  Recognition of the start codon results in the 
CHAPTER I  
 
2 
dissociation of initiation factors, joining of the 60S subunit, and entrance into the 
elongation phase.  Elongation describes the iterative process starting with the 
delivery of aminoacylated tRNA to the A-site, followed by peptide-bond formation 
(catalyzed by the ribozyme activity within the 60S subunit), and translocation to 
the adjacent mRNA codon (Dever and Green 2012).1  
Canonical translation termination begins when the ribosome encounters 
an in-frame stop codon (UAG, UAA, or UGA).  In bacteria, release factors RF1 or 
RF2 (RF1/2) associate with the ribosome at the A-site and sense the presence of 
a stop codon.  This recognition step induces a conformational change in RF1/2 
such that the conserved GGQ motif moves to the peptidyl-transferase center to 
catalyze peptidyl-tRNA hydrolysis and peptide release (Korostelev 2011).  The 
GTPase RF3 binds to the ribosome and catalyzes the release of RF1/2 and RF3 
upon GTP hydrolysis.  Finally, the ribosome recycling factor RRF and elongation 
factor EF-G associate with the ribosome and catalyze ribosome subunit 
dissociation (Schmeing and Ramakrishnan 2009).  Once initiation factor-3 (IF3) 
binds to the small subunit and facilitates mRNA and deacylated-tRNA release, 
both subunits are ready to be recycled for subsequent rounds of translation 
																																																						
	
1 For a more in-depth review of eukaryotic initiation and elongation, refer to 
(Rodnina and Wintermeyer 2009; Aitken and Lorsch 2012; Dever and Green 
2012; Voorhees and Ramakrishnan 2013). 
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(Dever and Green 2012; Keiler 2015).  In eukaryotes, release factors eRF1 and 
eRF3, which bear no sequence homology to bacteria RF1/2, bind to the 
ribosome at the A-site (Schmeing and Ramakrishnan 2009; Korostelev 2011).  
eRF1 consists of three domains that fold into a tRNA-like structure and 
recognizes the stop codon (Song et al. 2000; Brown et al. 2015).  The N-terminal 
domain (domain I) is similar to the tRNA anticodon loop, the middle domain 
(domain II) is similar to the tRNA acceptor arm and contains the catalytic GGQ 
motif, and the C-terminal domain (domain III) is similar to the tRNA T stem (Song 
et al. 2000; Graille and Séraphin 2012).  Stop codon recognition triggers the 
GTPase activity of eRF3, which is followed by the dissociation of GDP-bound 
eRF3 and accommodation of eRF1 into the catalytically active state.  The 
ATPase ABCE1 binds to the ribosome and holds eRF1 in the active state to 
promote eRF1-mediated peptidyl-tRNA hydrolysis and peptide release.  Finally, 
ABCE1 and eRF1 dissociate the ribosome subunits in a ATPase-dependent 
manner (Shoemaker and Green 2011; Graille and Séraphin 2012; Preis et al. 
2014).  Individual subunits are then recycled for new rounds of translation (Dever 
and Green 2012). 
Given the highly complex, multistep process, it is no surprise that cells 
possess quality control mechanisms to ensure the functional integrity of mRNA-
to-protein translation.  And while overt issues, such as mRNAs lacking a 5' cap, 
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are readily detected and dealt with during mRNA and ribosome maturation (Jiao 
et al. 2010; Peña et al. 2017), subtle errors, such as those embedded within the 
mRNA or rRNA sequences (Figure 1.1), can still make their way into the 
translation cycle.  Aberrant sequence features include mRNAs lacking a stop 
codon, encoding strong secondary structures, containing stretches of 
polyadenosine (poly(A)), etc., all of which could lead to the stalling of the 
associated ribosome (Shoemaker and Green 2012).2  Ribosome stalling events 
are frequent, with reports indicating that two to four percent of E. coli ribosomes 
are stalled and in need of rescue (Ito et al. 2011; Keiler 2015).  The complexity of 
the eukaryotic translation machinery suggests that ribosome stalling is also 
problematic in higher organisms.  Without quality control, stalled ribosomes could 
potentially deplete the pool of translationally available ribosomes.  Ribosome 
stalling can also lead to the generation of truncated, nonfunctional proteins, 
whose accumulation can activate cellular stress response (Gregersen et al. 
2006; Walter and Ron 2011).  Thus, rapid clearance of aberrant mRNA and the 
																																																						
	
2 A premature stop codon within the mRNA open reading frame (ORF) triggers 
quality control known as nonsense-mediated decay (NMD).  Although NMD 
depends on ongoing translation, the mechanism of ribosome rescue and mRNA 
decay largely deviates from other translation-dependent quality control pathways 
and, thus, will not be discussed here.  Instead, see (Kervestin and Jacobson 
2012) for a detailed review. 
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associated nascent peptide prevents ribosomes from reengaging on the same 
mRNA and protects cells against the accumulation of defective protein products. 
 
Translation-dependent quality control in bacteria 
Trans-translation 
Bacteria mRNAs lacking a stop codon can arise from ribosomal 
frameshifting, read-through of intact stop codons, premature transcription 
termination of the mRNA, endonucleolytic cleavage of the mRNA, etc.  
Consequently, ribosomes associated with non-stop mRNAs become stuck at the 
3' end.  There are currently three known mechanisms in bacteria that rescue 
ribosomes stalled on non-stop mRNAs (Keiler 2015).  The first one, the trans-
translation pathway, was initially discovered with the observation that nascent 
peptides containing a specific 11-amino acid tag were rapidly degraded.  The 
gene responsible for the peptide tag (E. coli ssrA) encodes a unique RNA 
sequence that contains both mRNA- and tRNA-like properties, coined transfer-
messenger RNA (tmRNA) (Keiler et al. 1996; Keiler 2015).  The mRNA-like 
domain encodes the peptide tag while the 5' and 3' ends fold into a secondary 
structure – similar to a tRNA acceptor arm – that is aminoacylated with alanine.  
The complex formed by tmRNA and its binding partner small protein B (SmpB) 
resembles a complete tRNA molecule (Keiler et al. 1996; Karzai et al. 1999; 
CHAPTER I  
 
6 
Bessho et al. 2007; Neubauer et al. 2012; Keiler 2015).  Together with GTP-
bound EF-Tu, the tmRNA-SmpB complex binds to the empty A-site of the stalled 
ribosome (Neubauer et al. 2012; Keiler 2015).  Structural studies place the SmpB 
protein at the ribosome decoding center normally occupied by the tRNA 
anticodon loop, with the SmpB C-terminal tail positioned downstream of the A-
site well into the mRNA entrance channel (Neubauer et al. 2012).  SmpB acts as 
a sensor for non-stop complexes since the presence of an mRNA within the 
entrance channel would sterically clash with the SmpB C-terminal tail (Neubauer 
et al. 2012).  The ribosome resumes translation on the tmRNA's mRNA-like 
domain that encodes the peptide tag, and continues elongating until it reaches 
the tmRNA stop codon sequence.  The ribosome subsequently undergoes 
canonical termination and subunit dissociation (Keiler 2015).  In addition, the 
associated non-stop mRNA is usually cleaved and rapidly degraded to prevent 
further translation of the aberrant transcript (Yamamoto et al. 2003; Ivanova et al. 
2004; Keiler 2015; Ferrin and Subramaniam 2017). 
 
ArfA and ArfB 
In addition to trans-translation, some bacteria contain redundant pathways 
that rescue ribosomes stalled on non-stop mRNAs.  In the ArfA pathway, the 
ArfA (yhdL) protein associates with stalled ribosomes and recruits RF2 for the 
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hydrolysis of the peptidyl-tRNA (Keiler 2015; Demo et al. 2017).  ArfA recognizes 
an empty A-site, with its N-terminus positioned near the decoding center and its 
C-terminus occupying the mRNA channel.  Recent electron cryomicroscopy 
(cryo-EM) structures of ArfA bound to non-stop complexes suggest ArfA 
functionally mimics a stop codon, and its binding allows for stable association of 
a compact, inactive RF2 with the ribosome (James et al. 2016; Demo et al. 
2017).  Rearrangement of the ArfA N-terminus is coupled to the conformational 
change of RF2 from the compact, inactive state to an open, active state.  Only in 
the active state is the RF2 GGQ motif positioned at the peptidyl-transferase 
center and primed for catalyzing the hydrolysis of peptidyl-tRNA (James et al. 
2016; Demo et al. 2017; Huter et al. 2017; Ma et al. 2017).  In E. coli, ArfA is 
essential for viability in the absence of a functional trans-translation pathway 
(ssrA-) (Chadani et al. 2010), and evidence suggests the ArfA pathway functions 
as a backup to the trans-translation pathway via a negative feedback loop.  Due 
to its secondary structure, the ArfA mRNA is cleaved by RNase III and the 
resulting mature mRNA lacks a stop codon.  The ArfA mRNA forms non-stop 
ribosome complexes and is targeted for the trans-translation pathway.  However, 
when the trans-translation pathway is limited, ArfA evades tmRNA peptide 
tagging and functional ArfA protein remains intact (Chadani et al. 2011a; Garza-
Sánchez et al. 2011).   
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The ArfB pathway was discovered only when both the trans-translation 
and ArfA pathways were inactivated during a screen of multicopy suppressors of 
the lethal ssrA∆	arfA∆ phenotype (Chadani et al. 2011b).  ArfB (YaeJ), which has 
homology to the GGQ catalytic domain of RF1/2, binds to the stalled ribosome 
and initiates peptidyl-tRNA hydrolysis (Handa et al. 2011).  Structural studies 
place the ArfB C-terminal tail downstream of the A-site in the mRNA entrance 
channel, suggesting this domain acts as a sensor for non-stop complexes.  
Stable association of the C-terminal tail induces conformational changes in ArfB 
that leads to the placement of the GGQ motif in the peptidyl-transferase center 
(Gagnon et al. 2012).  Unlike the trans-translation pathway, ArfA and ArfB do not 
promote the rapid degradation of the nascent peptide or associated mRNA 
(Keiler 2015). 
 
Translation-dependent quality control in eukaryotes 
No-go Decay (NGD) 
Eukaryotes also possess surveillance mechanisms that resolve stalled 
ribosomes.  No-go decay occurs when an mRNA sequence feature stalls or 
severely slows down associated ribosomes.  These aberrant mRNAs are 
targeted by surveillance machinery, starting with the endonucleolytic cleavage of 
the mRNA in the vicinity of the stall site, followed by rapid degradation by the 
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cytoplasmic 5' → 3' (Xrn1p) and 3' → 5' (exosome) decay factors (Shoemaker 
and Green 2012).  This process was initially discovered in S. cerevisiae when 
researchers expressed a plasmid encoding a pgk1 variant that contained a stem 
loop within the ORF (PGK1-SL) (Doma and Parker 2006); this strong secondary  
 
Figure 1.1: Aberrant RNA sequence features  
Aberrant RNA sequence features that trigger non-stop decay (NSD), no-go 
decay (NGD), peptide dependent translation arrest (PDTA) or ribosome quality 
control (RQC), and 18S nonfunctional rRNA decay (18S NRD).  mRNAs lacking 
a stop codon but contain a poly(A) tail are subject to NSD.  mRNAs containing a 
strong secondary structure within the ORF or mRNAs lacking both a stop codon 
and poly(A) tail are subject to NGD.  mRNAs containing stretches of poly(A) or 
rare codons within the ORF are subject to PDTA/RQC.  18S rRNA containing 
mutations within the decoding center is subject to 18S NRD. 
AAAA(n)STOPAUG
AAAA(n)AUG
AAAAAAAAA AAAA(n)STOPAUG
CGACGACGA AAAA(n)STOPAUG
AUG
AAAA(n)STOPAUGnormal mRNA
NSD
NGD
PDTA/RQC
AAAA(n)STOPAUG18S NRD
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structure was previously shown to stall ribosomes (Hosoda et al. 2003).  Yeast 
rapidly degraded PGK1-SL, even in the absence of DCP2 (decapping complex) 
or SKI7 (Ski complex; 3' → 5' decay).  However, strains lacking XRN1 or 
components of the Ski complex accumulated 5' and 3' PGK1-SL fragments, 
which disappeared when translation initiation on the PGK1-SL mRNA was 
prevented (Doma and Parker 2006).  This suggests NGD occurs during 
translation elongation and is initiated by an endonucleolytic cleavage event.  
Other sequence features that stall ribosomes (including pseudoknots, rare 
codons, GC-rich regions, and abasic sites) also induce a cleavage event (Doma 
and Parker 2006; Gandhi et al. 2008; Passos et al. 2009; Kuroha et al. 2010; 
Tsuboi et al. 2012). 
The discovery of NGD led to the finding that Dom34p (mammalian Pelota) 
and Hbs1p, homologs to eRF1 and eRF3 respectively, are required for the 
release of stalled ribosomes (Shoemaker et al. 2010; Tsuboi et al. 2012).  In S. 
cerevisiae, the Dom34p:Hbs1p heterodimer binds to the ribosome at the A-site 
(Figure 1.2), and GTP hydrolysis by the GTPase activity of Hbs1p promotes 
subunit dissociation (Shoemaker et al. 2010; Pisareva et al. 2011).  Similar to 
eRF1, Dom34p consists of three domains: N-terminal domain (N), middle domain 
(M), and the C-terminal domain (C) (Graille et al. 2008; Pisareva et al. 2011).  
The M and C domains are homologous to the eRF1 domains II and III, but the 
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Dom34p N domain differs in that it adopts an Sm-fold (Chen et al. 2010).  Cryo-
EM data of Dom34p:Hbs1p bound to non-stop ribosome complexes place the 
Dom34p N domain at the A-site, occupying the same space as the tRNA 
anticodon region.  The N domain also contains a loop that extends into the 
mRNA channel, suggesting that Dom34p recognizes an empty A-site (Hilal et al. 
2016).  Alternatively, this extension may destabilize shortened mRNA, as in the 
case of NGD complexes with mRNAs occupying the A-site and the downstream 
entrance channel (Shoemaker et al. 2010; Becker et al. 2011; Pisareva et al. 
2011; Hilal et al. 2016; Shao et al. 2016).  Unlike eRF1 domain II, the M domain 
of Dom34p lacks the catalytic GGQ motif (Graille et al. 2008; Hilal et al. 2016), 
consistent with the observation that subunit dissociation facilitates the release of 
an intact peptidyl-tRNA (Shoemaker et al. 2010).  The body of Hbs1p folds 
similarly to the translational GTPase eRF3 and is organized into three domains: 
GTPase domain (G), domain II, and domain III.  Hbs1p also contains a unique 
globular N-terminal domain that is attached to the body via a flexible linker.  
Hbs1p domains II and III interact with domains M and C of Dom34p, with their 
overall structural interaction comparable to that of eRF1-eRF3-GTP (Chen et al. 
2010).  Hbs1p holds Dom34p in the inactive state until GTP hydrolysis triggers 
the accommodation of Dom34p into the active state (Hilal et al. 2016).  The N-
terminal domain of Hbs1p resides near the mRNA entrance channel, between 
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h16 and ribosomal protein S3 (Rps3p; uS3), possibly acting as another sensor 
for an empty A-site or truncated mRNA (Becker et al. 2011; Pisareva et al. 2011; 
Shoemaker and Green 2011; Franckenberg et al. 2012; Hilal et al. 2016).  While 
Dom34p:Hbs1p alone can dissociate ribosome subunits, biochemical 
experiments not only demonstrate that the ATPase Rli1p (mammalian ABCE1) 
can function with Dom34p in subunit dissociation, but that Rli1p binding 
significantly accelerates the splitting rate (Pisareva et al. 2011; Shoemaker and 
Green 2011). 
 
Non-stop Decay (NSD) 
Non-stop decay targets ribosomes stalled at the 3' end of mRNAs lacking 
a stop codon (Shoemaker and Green 2012).  Yeast genetic studies 
demonstrated rapid degradation of an mRNA reporter that lacks a stop codon in 
the ORF or 3' untranslated region (UTR).  This degradation was dependent on 
on-going translation since the addition of cycloheximide or depletion of charged 
tRNAs stabilized the non-stop transcript.  Studies also showed that rapid 
degradation occurred in the absence of the major turnover factors, XRN1 (5' → 3' 
exonuclease), DCP1 (decapping complex), or CCR4 (deadenylase complex) 
(Frischmeyer et al. 2002).  Rather, the Ski complex and the 3' → 5' exosome was 
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found to mediate the degradation of non-stop transcripts (van Hoof et al. 2002; 
Wilson et al. 2007). 
The Ski complex binds to the small subunit of non-stop ribosomes and 
directs the exosome 3' → 5' degradation of non-stop mRNAs (Wang et al. 2005; 
Kowalinski et al. 2016; Schmidt et al. 2016a).  The Ski complex consists of three 
proteins: Ski2p, Ski3p, and Ski8p.  Structural data place Ski2p, a DExH-box 
helicase, near the mRNA entrance channel where it is positioned to feed the 
mRNA substrate into the exosome (Halbach et al. 2013; Schmidt et al. 2016b).  
The N-terminal region of the tetratricopeptide (TRP) protein Ski3p, and one copy 
of the WD-repeat3 protein Ski8p, make additional interactions with the 40S 
subunit; a second copy of Ski8p binds to the surface-exposed Ski3p (Schmidt et 
al. 2016a).  Mediating the physical interaction between the Ski complex and the 
exosome is the eRF3-like factor Ski7p (Araki et al. 2001; Wang et al. 2005; 
Kowalinski et al. 2016).  The Ski7p GTP-binding domain, domain II, and domain 
III all reside in the C-terminus, whereas the N-terminus houses distinct regions 
for exosome- and Ski complex-binding (Kowalinski et al. 2015; 2016).  
Immunoprecipitation experiments demonstrated direct binding of Ski7p to Ski8p 
and to multiple regions of Ski3p; these interactions allow for the indirect binding 
																																																						
	
3 Tryptophan (W) and aspartic acid (D) repeats 
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of Ski7p to Ski2p (Brown et al. 2000; Araki et al. 2001; Wang et al. 2005).  With 
Ski7p being a stable component of the cytoplasmic exosome – and the 
observation that the Ski complex directly interacts with the ribosome in the 
absence of SKI7 – the Ski complex likely recruits a preassembled Ski7p-
exosome complex to the ribosome to initiate non-stop mRNA degradation 
(Kowalinski et al. 2016; Schmidt et al. 2016a). 
Non-stop complexes can form from a variety of aberrant mRNA species.  
The read-through or complete lack of an in-frame stop-codon would result in 
ribosomes associated with the 3' UTR, poly(A) tail, or the 3' end of the mRNA.  
Alternatively, an endonucleolytic cleavage event within the ORF (as in the case 
with NGD substrates) would result in a ribosome complex stuck at the very 3' end 
of the mRNA.  The formation of non-stop complexes from a NGD substrate have 
led researchers to speculate that the same NGD factors might also play a role in 
NSD.  Indeed, both Dom34p and Hbs1p function in NSD by dissociating 
ribosomes stalled at the 3' end of the mRNA (Tsuboi et al. 2012; Saito et al. 
2013a; Guydosh and Green 2014).  This suggests NSD and NGD describe the 
same surveillance mechanism and differ only in the type of stalled ribosome 
complex that initiated the pathway. 
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Peptide-Dependent Translation Arrest (PDTA) 
While NGD and NSD were discovered by examining the fate of aberrant 
mRNA, PDTA was discovered by examining the fate of the nascent peptide.  
Yeast expression of a plasmid encoding either stretches of positively-charged 
((+)-charged) amino acids, poly(A) stretches, or rare codons resulted in rapid 
degradation of the associated nascent peptide (Dimitrova et al. 2009; Ikeuchi and 
Inada 2016).  PDTA mRNAs likely stall or severely slow down ribosomes since 
stretches of (+)-charged amino acids can make electrostatic interactions with the 
ribosome's negatively-charged peptide channel (Lu et al. 2007; Requião et al. 
2016), and rare codons reduce translation efficiency (Letzring et al. 2010; 2013; 
Wolf and Grayhack 2015).  Furthermore, PDTA mRNAs are subject to 
endonucleolytic cleavage (Kuroha et al. 2010; Chen et al. 2010; Tsuboi et al. 
2012; Guydosh and Green 2017), suggesting they are also targets for NGD.  
Indeed, NGD factors Dom34p and Hbs1p facilitate endonucleolytic cleavage and 
dissociate the 60S and 40S subunits of stalled PDTA complexes (Kuroha et al. 
2010; Tsuboi et al. 2012).  
A screen of S. cerevisiae mutants suppressing PDTA activity identified 
ASC1 (mammalian RACK1) as a required factor.  Asc1p is a highly conserved, 
stoichiometric component of the 40S ribosomal subunit (Figure 1.2) (Coyle et al. 
2009).  Without ASC1, protein products from PDTA mRNAs are stabilized 
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Figure 1.2: Structure of Dom34p:Hbs1p in complex with the ribosome   
Cryo-EM structure of the yeast 80S ribosome in complex with Dom34p (orange), Hbs1p (red), P-site tRNA 
(yellow), and mRNA (black).  Shown in green is the ribosomal protein Asc1p (PDB: 5M1J) 
(Hilal et al. 2016).
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(Kuroha et al. 2010; Ikeuchi and Inada 2016).  It was thought that Asc1p 
promoted stalling of the ribosome (Kuroha et al. 2010; Inada 2013; Letzring et al. 
2013), but more recent data suggest Asc1p is involved in targeting stalled 
ribosomes for quality control (Sitron et al. 2017). 
Asc1p belongs to a class of WD-repeat (Trp-Asp) proteins and folds into a 
seven-bladed beta-propeller structure (Coyle et al. 2009).  It was originally 
identified as an activator of Protein Kinase C (PKC), hence its mammalian name 
Receptor for Activated C Kinase 1 (RACK1) (Ron et al. 1994; 1999).  This 
eukaryotic-specific factor is highly conserved from yeast to humans and, like 
other WD proteins, acts as a scaffold for multiple proteins.  Indeed, RACK1 has 
been implicated in many signal transduction pathways, including the Src kinase, 
MAP kinase, and cAMP-specific phosphodiesterase PDE4D5 pathways (McCahill 
et al. 2002; Rachfall et al. 2013).  In higher eukaryotes, loss of RACK1 is 
embryonic lethal with disruptions to neural tube closure, post-synaptic function in 
neurons, and cell migration (Ron et al. 1999; Yaka et al. 2002; Kiely et al. 2009; 
Wehner et al. 2011).  In yeast, deletion of ASC1 leads to slow growth, loss of cell 
wall integrity, loss of invasive growth (glucose sensing), and mitochondrial 
dysfunction (Valerius et al. 2007; Coyle et al. 2009; Melamed et al. 2010; 
Rachfall et al. 2013).  Both RACK1 and Asc1p primarily exist as ribosome-bound 
factors, specifically associating with 40S subunits in proximity to the mRNA exit 
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channel (Coyle et al. 2009; Ben-Shem et al. 2010; Anger et al. 2013).  Studies in 
mammalian cells show RACK1 participating in translation initiation by directing 
PKC phosphorylation of eIF64 (Ceci et al. 2003).  RACK1 has also been shown 
to promote ubiquitination of various proteins (Liu et al. 2007; Subauste et al. 
2009; Sundaramoorthy et al. 2017).  In yeast, loss of ASC1 increases ribosome 
frameshifting at CGA repeats (Wolf and Grayhack 2015).  Finally (as mentioned 
above), RACK1/Asc1p functions in ribosome quality control, where it promotes 
the degradation of nascent peptides associated with stalled ribosomes (Kuroha 
et al. 2010; Juszkiewicz and Hegde 2017; Sundaramoorthy et al. 2017). 
 
Ribosome Quality Control (RQC) 
RQC is similar to PDTA in that both describe the fate of nascent peptides 
associated with stalled ribosomes; however, RQC expands on the mechanism of 
peptide targeting and degradation (Brandman and Hegde 2016).  RQC was 
originally discovered during a genome-wide screen of S. cerevisiae loss-of-
function strains exhibiting high Heat Shock Factor 1 (Hsf1p) transcriptional 
activity.  This was accomplished by expressing a reporter encoding GFP driven 
by Hsf1p promoter elements, and monitoring Hsf1p activity by high-throughput 
																																																						
	
4 Dephosphorylated eIF6 prevents premature formation of 80S ribosomes by 
stably associating with free 60S subunits (Ceci et al. 2003; Brina et al. 2015). 
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flow cytometry.  The Hsf1p transcription factor activates genes in response to 
various stressors (e.g. heat shock); thus, the reporter system allowed for the 
identification of genes contributing to cellular homeostasis.  A prominent subset 
of translationally-related genes modulating Hsf1p activity included those of the 
RQC pathway.  Further experiments revealed Asc1p, Hel2p (an E3 ubiquitin 
ligase), Rqc1p, Rqc2p/Tae2p, Ltn1p (an E3 ubiquitin ligase), Cdc48p (an AAA 
ATPase), Npl4p (a cofactor of Cdc48p), and Ufd1p (a cofactor of Cdc48p) as 
protein components of the RQC pathway (Brandman et al. 2012).   
In the current model (Figure 1.3), Asc1p functions with Hel2p and the 
recently identified RQT complex (Slh1p:Cue3p:Rqt4p) in targeting stalled 
ribosomes for RQC engagement (Saito et al. 2015; Matsuo et al. 2017; Sitron et 
al. 2017).  Upon expression of a reporter mRNA encoding stretches of (+)-
charged amino acids, deletion of either ASC1, HEL2, or the RQT proteins led to 
the increased stability of associated nascent peptides (Kuroha et al. 2010; 
Brandman et al. 2012; Matsuo et al. 2017; Sitron et al. 2017).  Hel2p (along with 
its cofactors E2 ubiquitin-conjugating enzyme Ubc4p, E1 ubiquitin-activating 
enzyme Ube1p, and ubiquitin) ubiquitinates 40S proteins Rps3p (uS3; amino 
acid K212) and Rps20p (uS10; amino acids K6 and K8).  Notably, the K6/K8 
ubiquitination is required for RQC engagement (Matsuo et al. 2017).  Hel2p co-
sediments with polysomes, even in the absence of its RING domain or its Ubc4p 
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binding-site, suggesting Hel2p associates with ribosomes prior to ubiquitination 
(Matsuo et al. 2017).  The RQT complex associates with Hel2p-bound ribosomes 
and likely functions in recognizing Rps20p (uS10) ubiquitination via the ubiquitin-
binding CUE domain of Cue3p.  The ATPase activity of the RecA helicase Slh1p 
is required for targeting and subsequent RQC engagement, but the exact role of 
the ATPase activity is still unknown (Matsuo et al. 2017).  Work in mammalian 
cells using a poly(A) mRNA reporter demonstrates that the targeting of stalled 
ribosomes by Asc1p and Hel2p is highly conserved.  Both ZNF598 (yeast HEL2) 
and RACK1 (yeast ASC1) facilitate the ubiquitination of specific 40S proteins in 
stalled ribosomes.  ZNF598 primarily functions in RPS20 (uS10) and RPS10 
(eS10) ubiquitination, whereas RACK1 functions in RPS3 (uS3) and RPS2 (uS5) 
ubiquitination.  A similar ubiquitination pattern was apparent in cells treated with 
inhibitors of translation elongation or activators of the unfolded protein response 
(Higgins et al. 2015; Juszkiewicz and Hegde 2017; Sundaramoorthy et al. 2017).  
Finally, the current model places targeting upstream of ribosomal subunit 
dissociation given the evidence that DOM34 and HBS1 function in splitting 
ribosomes and that peptidyl-tRNA is stabilized in yeast lacking either factor 
(Tsuboi et al. 2012; Shao et al. 2013; Verma et al. 2013; Osuna et al. 2017). 
Once targeted, the RQC factors Rqc1p, Rqc2p, and Ltn1p associate with 
nascent-chain containing 60S subunits to tag the nascent peptide for 
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Figure 1.3: Ribosome Quality Control pathway  
Current model of Ribosome Quality Control (RQC).  Step 1) Recognition and targeting by Asc1p, Hel2p, and 
the RQT complex (Slh1p:Cue3p:Rqt4p).  Step 2) Subunit dissociation by Dom34p:Hbs1p and Rli1p.  
Endonucleolytic cleavage and degradation of mRNA.  Step 3) Assembly of remaining RQC factors.  CAT-
tailing by Rqc2p, nascent peptide ubiquitination by Ltn1p.  Step 4) Peptide extraction by 
Cdc48p:Ufd1p:Npl4p, complex dissociation, and peptide degradation by the proteosome.  Figure adapted 
from (Brandman and Hegde 2016).
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degradation.  This is accomplished by CAT-tail synthesis and/or ubiquitination.  
Rqc2p directs the template-independent addition of alanine and threonine 
extensions (CAT-tails) to the C-terminus of the nascent peptide (Shen et al. 
2015).  Rqc2p interacts with alanine- or threonine-charged tRNA, bringing the A-
site tRNA to the peptidyl-transferase center for the ribosome to catalyze peptide 
bond formation (Shao et al. 2015; Osuna et al. 2017).  Cryo-EM data revealed 
extensive interactions between the P-site tRNA and the N- and C-terminal 
domains of Rqc2p, suggesting that Rqc2p stabilizes P-site tRNA after 40S 
dissociation (Shao et al. 2015; Shen et al. 2015).  CAT-tailing also promotes 
Hsf1p transcriptional activation and is abrogated in the absence of Rqc2p in vivo 
and in vitro (Shen et al. 2015; Osuna et al. 2017).   
CAT-tailing appears to facilitate ubiquitination of the nascent chain 
(Brandman and Hegde 2016; Kostova et al. 2017; Osuna et al. 2017).  For 
example, when ribosomes stall due to stretches of (+)-charged amino acids, 
lysine residues would be enclosed within ribosome's exit channel and, therefore, 
would be unavailable for ubiquitination.  The addition of alanine and threonine 
residues to the nascent chain would move the lysine residues through the 
channel, eventually exposing them for post translational modification.  
Alternatively, if sufficient lysine residues were already exposed, ubiquitination 
and degradation of the nascent peptide proceeds regardless of CAT-tails (Shao 
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and Hegde 2014; Shen et al. 2015; Choe et al. 2016; Defenouillère et al. 2016; 
Yonashiro et al. 2016; Kostova et al. 2017; Osuna et al. 2017).  In addition to 
CAT-tail synthesis, Rqc2p functions in CAT-tail termination by promoting 
hydrolysis of the peptidyl-tRNA.  Although the exact mechanism remains unclear, 
it was shown that peptidyl-tRNA was stabilized in the absence of RQC2 (Osuna 
et al. 2017).   
While Rqc2p promotes CAT-tailing, the E3 ubiquitin ligase Ltn1p 
ubiquitinates the nascent peptide of stalled complexes in an Rqc1p-dependent 
manner (Osuna et al. 2017).5  Biochemical experiments showed that Ltn1p is 
able to distinguish nascent chains associated with 60S subunits from 80S 
ribosomes; therefore, ribosomal subunit dissociation must occur before 
ubiquitination by Ltn1p (Shao et al. 2013; Shao and Hegde 2014).  Structural 
studies place the RING domain (the binding site of E2 ubiquitin-conjugating 
enzyme) near the peptide exit channel (Shao et al. 2015), priming Ltn1p to 
ubiquitinate the emerging nascent chain.  Of note, the positioning of both Rqc2p 
and Ltn1p on the 60S subunit effectively blocks the 40S subunit from re-
associating (Shao et al. 2015; Shen et al. 2015).   
																																																						
	
5 The role of Rqc1p in ubiquitination remains elusive, but authors have 
speculated that Rqc1p either helps position the nascent chain near the Ltn1p 
RING domain, stimulates Ltn1p's ligase activity, or promotes E2 binding (Osuna 
et al. 2017). 
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The final steps of the current model describe the degradation of the 
peptide.  Tagging by polyubiquitination initiates the association of the AAA+ 
ATPase Cdc48p and its cofactors Ufd1p and Npl4p for extraction of the nascent 
peptide.  Based on its role in the endoplasmic reticulum associated protein 
degradation (ERAD), it is believed that Cdc48p uses its ATPase activity to pull 
the tagged nascent peptide from the 60S subunit, consequently freeing the 
peptide for degradation by the proteasome (Brandman et al. 2012; Wolf and 
Stolz 2012; Verma et al. 2013; Brandman and Hegde 2016). 
 
Nonfunctional rRNA Decay (NRD) 
NRD describes the surveillance of nonfunctional 18S (18S NRD) and 25S 
(25S NRD) ribosomal RNAs (LaRiviere et al. 2006; Cole and LaRiviere 2008; 
Cole et al. 2009).  Previous work from our laboratory monitored the fate of 
mature but functionally defective S. cerevisiae rRNAs that contained inactivating 
mutations in the 18S rRNA decoding center (equivalent to G530U, U534G, or 
A1492C in E. coli 16S rRNA) or the 25S rRNA peptidyl-transferase center 
(equivalent to A2451G, C2452U, or U2585A in E. coli 23S rRNA).  These 
mutations were embedded in a plasmid encoding the entire 35S pre-rRNA 
sequence driven by the polymerase II promoter GAL7.  The plasmid-derived 
rRNA also contains benign sequence tags that enable specific detection of the 
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reporter rRNA amongst total rRNA via northern blot analysis (LaRiviere et al. 
2006; Cole and LaRiviere 2008).  Induction of transcription by galactose 
produces reporter rRNA that makes up only 1% of total rRNA (LaRiviere et al. 
2006).  Thus, 18S NRD kinetics can be monitored by performing a transcriptional 
pulse chase (Cole and LaRiviere 2008).  Like their corresponding wild-type 
rRNAs, mutant rRNAs are synthesized, processed, and assembled into 
structurally intact ribosomes.  However, the mutant 18S and 25S rRNAs are 
eliminated by mechanistically distinct pathways (LaRiviere et al. 2006; Cole et al. 
2009). 
In 25S NRD, 60S subunits containing mutant 25S rRNA cannot form 
stable 80S monosomes, and mutant 25S rRNA localize to perinuclear foci.  
Further, yeast preserve 25S NRD in the presence of the translation elongation 
inhibitor cycloheximide, indicating 25S NRD is not dependent on ongoing 
translation (LaRiviere et al. 2006; Cole et al. 2009).  Finally, 25S NRD involves 
DNA damage repair factors MMS1 and RTT101 (an ubiquitin E3 ligase) (Fujii et 
al. 2009).  60S subunits containing mutant 25S rRNA are tagged with ubiquitin in 
a Mms1p:Rtt101p-dependent manner, which is subsequently recognized by the 
Cdc48p:Ufd1p:Npl4p complex and the proteasome (Fujii et al. 2012).  Since 25S 
NRD still occurs in yeast lacking XRN1 or SKI7 (Cole et al. 2009), it remains 
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unknown how exactly mutant 25S rRNA is removed from the 60S subunit and 
degraded. 
In contrast, 18S NRD exhibits similar characteristics of other translation-
dependent pathways (Figure 1.4).  Like wild-type rRNA in translating ribosomes, 
mutant 18S rRNA displays diffuse cytoplasmic localization, and co-sediments 
with 40S subunits and 80S monosomes – mutant 18S rRNA also co-sediments 
with polysomes but to a much lesser extent (LaRiviere et al. 2006; Cole et al. 
2009).  Treatment with cycloheximide completely abrogates 18S NRD, 
demonstrating its dependence on ongoing translation (Cole et al. 2009).  
Furthermore, 18S NRD involves a number of factors implicated in other 
translation-dependent surveillance pathways.  18S NRD kinetics is significantly 
reduced in the absence of either DOM34, HBS1, ASC1, or SKI7 (Cole et al. 
2009).  Double deletion of DOM34 and HBS1 only partially stabilizes mutant 18S 
rRNA (Cole et al. 2009), consistent with the model that the Dom34p:Hbs1p 
heterodimer function in the same pathway by dissociating ribosomal subunits.  
On the other hand, a dom34∆ strain lacking ASC1 completely abrogates 18S 
NRD (Merrikh 2012).  Thus, 18S NRD appears to consist of two genetically 
separable pathways, one involving ASC1 and the other involving DOM34:HBS1.  
Examination of the cryo-EM structure of the yeast 80S ribosome in complex with 
Dom34p:Hbs1p revealed that the ribosomal protein S3 (uS3) structurally  
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Figure 1.4: Shared mechanisms among 18S NRD and other translation-
dependent quality control pathways 
18S NRD, NGD, PDTA, and RQC are all initiated by ribosomal stalling.  
Mutations within the 18S rRNA decoding center lead to ribosomal stalling, 
whereas aberrant mRNAs containing strong secondary structures (NGD), 
stretches of CGA repeats, or basic amino acids (PDTA/RQC) stall ribosomes.  
Ribosome stalling is recognized by the splitting factors Dom34p:Hbs1p in all 
pathways.  After subunit dissociation, cytoplasmic exonucleases degrade 
problematic RNAs (18S NRD and NGD), while the proteasome degrades the 
nascent peptide (PDTA/RQC). 
 
interacts with Hbs1p and Asc1p, leading us to predict that RPS3 might be 
involved in 18S NRD.  Chapter II of this thesis investigates whether RPS3 
contributes to the rapid decay of mutant 18S rRNA and confirms the role of ASC1 
in 18S NRD. 
 
	  
Asc1/RACK1
Dom34 Hbs1 Dom34 Hbs1Dom34 Hbs1
18S NRD NGD PDTA and RQC
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RNA Damage 
Normal metabolic byproducts and environmental factors can negatively 
affect cellular function by damaging macromolecules.  Although a considerable 
amount of work has focused on pathways that deal with damaged proteins, lipids, 
and DNA (Doetsch and Cunningham 1990; Demple and Harrison 1994; Gros et 
al. 2002; Niki 2014), little is known about the cellular responses to RNA damage.  
Numerous studies have shown that RNA is highly susceptible to oxidation, 
alkylation, and irradiation that result in aberrant RNA modifications (Wurtmann 
and Wolin 2009) (Figure 1.5); such lesions could lead to ribosome stalling and 
protein miscoding (Simms and Zaher 2016).  Since translation-dependent quality 
control mechanisms target stalled ribosomes, recent data implies that damaged 
RNA may stand in as a possible substrate (Simms et al. 2014; Calabretta et al. 
2015; Hudson and Zaher 2015; Jamar et al. 2017).  In addition, damaged RNA 
has been linked to many diseases, including amyotrophic lateral sclerosis (ALS), 
Alzheimer's, and Parkinson's (Zhang et al. 1999; Shan et al. 2003; Chang et al. 
2008; Nunomura et al. 2009), but whether this is merely an outcome of the 
pathology, or part of the cause, remains elusive.  The amount of unanswered 
questions points to a need for higher-resolution tools to further our knowledge on 
how cells deal with damaged RNA. 
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Figure 1.5: Types of RNA damage 
Different types of damaging agent-induced adducts.  ROS: reactive oxygen 
species; 8oxoG: 8-oxoguanosine; MMS: methyl methanesulfonate; O6-meG: O6-
methylguanosine; UV: ultraviolet; Pt-RNA: platinated RNA. 
 
Types of damage and molecular consequences 
Ultraviolet (UV) radiation 
Irradiation of purified RNA induces several types of photoproducts, 
including cyclobutane pyrimidine dimers, uridine hydrate, and cytidine hydrate.  
These products are more likely to occur in single-stranded RNA than double-
stranded RNA (Pearson and Johns 1966; Pearson et al. 1966; Miller and Cerutti 
1968; Remsen et al. 1970; Holmes and Singer 1971; Wurtmann and Wolin 2009; 
Kladwang et al. 2012).  Several lines of work suggest UV-irradiated RNA can 
substantially impact RNA-based methods, cellular components, and cellular 
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function.  For instance, one group noted significant RNA damage upon UV-
shadowing (Kladwang et al. 2012).  Gel-purification of RNA is routinely practiced 
during the preparation of RNA deep-sequencing libraries, and many laboratories 
use hand-held UV lamps to visualize RNA within gels.  However, even at low-
energy settings, UV-shadowing induces damaging photo lesions in RNA samples 
(Kladwang et al. 2012).  Moreover, gel-purification of size-selected RNA often 
precedes the reverse transcription step for some specialized deep-sequencing 
libraries (Ingolia et al. 2012).  Since reverse transcriptase tends to stop at 
pyrimidine dimers (Iordanov et al. 1998; Kladwang et al. 2012), incomplete cDNA 
synthesis can bias downstream analyses.6 
In vivo studies of cells irradiated with UV revealed extensive cross-linking 
between ribosomal proteins and RNA that coincides with reduced global 
translation (Stiege et al. 1986; Iordanov et al. 1998; Casati 2004).  UV-irradiation 
also induces the conserved ribotoxic stress response7.  Upon exposure to UV 
radiation, mammalian 28S rRNA acquired specific sites of damage, notably in the 
																																																						
	
6 On the other hand, the cross-linking effects of UV-irradiation have proven to be 
an asset in certain experimental designs, such as those aimed at identifying 
sequence targets of RNA-binding proteins (Greenberg 1979; Hafner et al. 2010). 
7 A signaling pathway that is initiated in response to treatment with ribotoxins 
ricin A chain or alpha-sarcin (Iordanov et al. 1997).  Ribotoxins cleave the 60S 
sarcin-ricin loop (SRL), a highly conserved rRNA domain that facilitates 
elongation by anchoring EF-G to the ribosome during translocation (Wool et al. 
1992; Shi et al. 2012); thus, ribotoxins essentially inactivate ribosomes. 
CHAPTER I  
 
31
peptidyl transferase center and the sarcin-ricin loop (SRL).  Furthermore, cellular 
response to UV-exposure requires actively translating ribosomes as a 
prerequisite for the activation of several kinases and the transcriptional induction 
of stress-related genes (Iordanov et al. 1998).  Another study demonstrated a 
connection between UV-irradiated RNA and skin inflammation (i.e. sunburn) 
(Bernard et al. 2012).  Exposing keratinocytes to UV radiation induces cytokine 
production from neighboring, non-irradiated keratinocytes via activation of the 
Toll-like receptor 3 (TLR3).  UV-exposure also induces changes to RNA 
secondary structure, specifically the noncoding snU1 RNA.  The authors were 
able to show that purified UV-irradiated snU1 RNA, as well as lysate from UV-
exposed cells, was sufficient to induce TLR3 activation.  Therefore, irradiated 
cells release damaged snU1 RNA, which then serves as a signaling molecule for 
TLR3-mediated inflammatory response (Bernard et al. 2012).  
 
Platination 
Cisplatin, carboplatin, and oxaliplatin are platinum-based 
chemotherapeutic drugs often used for the treatment of numerous cancers.  
Their utility has earned them a spot on the World Health Organization (WHO) List 
of Essential Medicines.  Platinum-based molecules react primarily with the N7 
position of guanosine to form intrastrand and interstrand crosslinks in nucleic 
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acids.  The cross-linking properties of platinum-based molecules can lead to cell-
cycle arrest and programmed cell-death (Rosenberg 1985).  While some 
literature attribute the antitumor activity of platinum-based molecules on their 
ability to damage DNA (Roberts and Thomson 1979; Rosenberg 1985; Siddik 
2003), emerging evidence indicates platination effects the chemical and 
functional integrity of RNA and RNA-related processes.  For instance, cisplatin 
treatment reduced the splicing activity of HeLa nuclear extracts in a dose-
dependent manner (Schmittgen et al. 2003).  Further, S. cerevisiae treated with 
micromolar amounts of cisplatin accumulated 4- to 20-fold more platinum-RNA 
products than DNA.  Most platinum-RNA products occurred on rRNA at 
functionally-relevant sites, with estimates of one to two platinum products 
occurring every three ribosomes (Hostetter et al. 2012; Osborn et al. 2014; 
Melnikov et al. 2016).  Cisplatin appears to inhibit both translation initiation and 
elongation.  An in vitro translation study using rabbit reticulocyte lysate 
demonstrated that cisplatin prevented the joining of 60S and 48S particles to 
form stable 80S complexes (Rosenberg and Sato 1993), while another study 
found that cisplatin arrested elongation (Heminger et al. 1997).  Although a direct 
link has yet to be shown, it is possible that the platinum effects on RNA-related 
processes might contribute to the neuropathies many cancer patients experience 
from cisplatin treatment (Windebank and Grisold 2008).  
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Alkylation 
Aberrant methylation of RNA can stem from endogenous sources, such as 
S-adenosyl methionine (SAM), or exogenous sources, such as methyl halides 
(found in pesticides and tobacco smoke) and many chemotherapeutic drugs 
(Drabløs et al. 2004; Sedgwick 2004; Simms and Zaher 2016).  The nitrogenous 
bases and phosphate backbone are all susceptible to methylation, with the 7-
methylguanosine being the most prevalent (Sedgwick 2004).  O6-
methylguanosine is highly mutagenic due to its ability to base pair with thymidine 
or uridine.  Kinetic studies using a reconstituted in vitro translation system 
determined the effects of O6-methylguanosine on the ribosome decoding process 
(Hudson and Zaher 2015).  The authors monitored peptide-bond formation by 
incubating purified bacteria-initiation complexes (carrying fMet-tRNA8 in the P-
site) with elongation factors, charged tRNA, and mRNA (with or without O6-
methylguanosine positioned at the A-site).  Cytidine:O6-methylguanosine pairs in 
the first and second codon:anticodon positions slowed ribosome decoding by 
100- to 1000-fold.  Uridine:O6-methylguanosine pairs in the second position also 
slowed ribosome decoding.  Conversely, ribosomes readily translated uridine:O6-
methylguanosine pairs occupying the first position, and cytidine:O6-
																																																						
	
8 N-formyl-methionyl tRNA (fMet-tRNA) is the bacteria-specific initiator tRNA  
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methylguanosine pairs in the third position (Hudson and Zaher 2015).  Thus, 
depending on the position of the modified codon, methyl adducts can either slow 
ribosome transit or permit incorrect tRNA selection.  Another study examined 
other types of methylated adducts on translation fidelity.  Depending on the 
location of the methyl group and the codon position of the methylated base, 
some adducts had no effect on translation whereas others inhibited it (You et al. 
2017).  Overall, these data suggest that mRNA containing methylated bases can 
severely slow down ribosomes or lead to the production of aberrant peptides.9 
 
Oxidation 
Cells generate reactive oxygen species (ROS) as a normal metabolic 
byproduct.  For example, the mitochondria electron chain transporter can 
prematurely leak oxygen, giving rise to the superoxide radical (⋅O2-) (Turrens 
2003).  Neutrophils also generate superoxide radicals during phagocytosis of 
																																																						
	
9 Interestingly, members of the AlkB-like family have been shown to demethylate 
RNA (Aas et al. 2003; Ougland et al. 2004; Jia et al. 2011; Vågbø et al. 2013), 
implicating a repair mechanism for methylated RNA.  However, RNA methylation 
is wide-spread and a normal part of the maturation and function of noncoding 
RNA (Decatur and Fournier 2002; Duechler et al. 2016; Liu et al. 2016).  
Methylated mRNA, such as N6-methyladenosine (m6A), has been recently 
implicated in regulating gene expression (Fu et al. 2014; Gilbert et al. 2016; 
Hoernes et al. 2016).  Therefore, it is unclear whether these enzymes necessarily 
repair methylated RNA or assist in the dynamic regulation of post transcriptional 
methylation (Wu et al. 2016). 
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invading microorganisms (Rada and Leto 2008).  Finally, peroxisomes produce 
many precursors of ROS, including hydrogen peroxide (H2O2) and nitric oxide 
(⋅NO)10, which can both pass through the peroxisomal membrane (Bonekamp et 
al. 2009).11  Many exogenous stressors can lead to the intracellular production of 
ROS.  UV radiation, inflammation, heat shock, or treatment with carcinogens or 
chemotherapeutic drugs have all been shown to increase intracellular ROS (Fiala 
et al. 1989; Nunoshiba and Demple 1993; Bruskov et al. 2002; Cadet et al. 2005; 
Rada and Leto 2008; Carozzi et al. 2010).  Bacteria, yeast, and mammalian cells 
treated with oxidizing agents have yielded more oxidized RNA than DNA.  8-oxo-
7,8-dihydroguanosine (8-oxoguanosine; 8oxoG) is the most prevalent product, 
however, 8-oxo-7,8-dihydroadenosine (8oxoA), 5-hydroxycytidine (5-HO-C), and 
5-hydroxyuridine (5-HO-U) have also been observed; 8oxoG is particularly 
mutagenic due to its ability to base pair with adenosine (Fiala et al. 1989; 
Yanagawa et al. 1990; 1992; Shen et al. 2000; Weimann et al. 2002; Hsu et al. 
2004; Hofer et al. 2005; 2006; Kim et al. 2006; Liu et al. 2012; Simms et al. 
2014). 
																																																						
	
10 H2O2 reacts with iron to produce the hydroxyl radical (⋅OH-) via Fenton's 
reaction (Walling 1975), and nitric oxide reacts with superoxide radicals to 
produce the oxidant peroxynitrite (ONOO-) (Bonekamp et al. 2009). 
11 It should be noted that cells contain a variety of enzymes that neutralize ROS.  
For instance, catalase breaks down H2O2, while superoxide dismutase (SOD1) 
catalyzes the disproportionation of the superoxide radical. 
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High levels of 8oxoG RNA have been linked with many neurodegenerative 
diseases.  For example, a mouse model of ALS (SOD1G93A) contained high levels 
of 8oxoG in the spinal cord motor neurons and oligodendrocytes.  This increase 
in oxidation occurred before the onset of behavioral symptoms associated with 
ALS (Chang et al. 2008).12  Human tissue samples from the spinal cord and 
motor cortices of ALS patients also contained high levels of 8oxoG RNA (Chang 
et al. 2008).  In addition, RNA oxidation has been observed in tissue samples of 
Alzheimer's patients (Nunomura et al. 1999; Abe et al. 2002; Shan et al. 2003; 
Ding et al. 2005; Shan and Lin 2006; Nunomura et al. 2012).  Hippocampal 
tissue immunostained with an antibody that specifically recognizes 8oxoG 
exhibited greater RNA oxidation in patient samples compared to age-matched 
tissues, where the amount of 8oxoG RNA positively correlated with cognitive 
decline (Nunomura et al. 1999; 2012).  These studies treated samples with 
RNAase prior to immunostaining to verify that the signal comes from 8oxoG RNA 
as opposed to 8oxoG DNA (Nunomura et al. 1999; 2002; Chang et al. 2008).  
Finally, other studies have found increased 8oxoG RNA in neurons of the 
substantia nigra and in the cerebrospinal fluid of patients with Parkinson's 
																																																						
	
12 Interestingly, another group treated cultured neurons with oxidizing agents and 
observed an increase in 8oxoG RNA that preceded neuronal cell death (Shan et 
al. 2007). 
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disease (Zhang et al. 1999; Abe et al. 2003).  Despite its prevalence, however, it 
remains unclear whether RNA oxidation directly contributes to the pathogenesis 
or is just a byproduct. 
Emerging evidence suggests RNA oxidation can have profound effects on 
translation.  In vitro translation of an oxidized mRNA substrate results in fewer 
protein products compared to non-oxidized mRNA (Shan et al. 2007).  A similar 
outcome was observed in mammalian cells transfected with oxidized mRNA 
(Shan et al. 2007; Tanaka et al. 2007).  Other studies have examined ribosome 
decoding kinetics on 8oxoG bases.  Using a high-resolution reconstituted 
translation system, one group demonstrated that cytidine:8oxoG or 
adenosine:8oxoG pairs in the first, second, or third codon:anticodon positions 
significantly slowed peptide-bond formation anywhere from 100- to 1000-fold 
(Simms et al. 2014).  The same group studied the translational effects of an 
mRNA reporter containing a single 8oxoG in eukaryotic extract.  The reporter 
yielded very little protein, even in the presence of protease inhibitors (Simms et 
al. 2014).  Another study developed an mRNA reporter containing a single 
oxidized base (8oxoG, 8oxoA, 5-HO-C, or 5-HO-U) upstream of a puromycin 
unit13 (Calabretta et al. 2015).  Translation of this reporter results in a peptide 
																																																						
	
13 Since puromycin functionally mimics the aminoacyl end of tRNA, ribosomes 
readily incorporate puromycin into the peptide chain.  Adding a puromycin unit to 
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product covalently linked to the mRNA, allowing for direct analysis of translation 
products on a denaturing gel (Roberts and Szostak 1997; Calabretta et al. 2015).  
The authors showed that in vitro translation of the reporter mRNA produced 
fewer full-length proteins while simultaneously increased the amount of abortive 
peptides whose length corresponded to the site of the lesion (Calabretta et al. 
2015).  Overall, these data indicate that oxidized mRNA can severely slow down 
ribosomes and prevent the production of full-length proteins. 
 
Relationship between damaged RNA and translation-dependent quality 
control  
As the above-mentioned studies suggest, certain damaging adducts in 
RNA can inhibit protein production by severely slowing (or stalling) ribosome 
elongation; therefore, one might predict that damaged RNA could trigger 
translation-dependent quality control.  Indeed, some research has provided 
evidence of a possible link between the two.  One study found that dom34# and 
xrn1# yeast had increased levels of 8oxoG RNA (Simms et al. 2014).  The 
dom34# lysates were enriched for 8oxoG RNA in the monosome and polysome 
fractions (Simms et al. 2014), implicating that Dom34p resolves ribosomes 
																																																						
	
the 3' end of an mRNA generates stable mRNA-peptide fusions that can be 
assayed directly on a denaturing polyacrylamide gel (Roberts and Szostak 1997). 
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stalled on 8oxoG RNA.  Yeast lacking components of the Ski complex (ski2#, 
ski3#, or ski8#) are highly sensitive to oxidative stress, and while single deletion 
of either SKI7, DOM34, or HBS1  tolerated H2O2 treatment similarly as wild-type 
yeast, the dom34#;ski7# or hbs1#;ski7# double-deletion strains exhibited 
increased sensitivity (Jamar et al. 2017).  These data suggest NGD and NSD 
factors help reduce the effects of oxidative stress.  The screen that eventually 
uncovered the RQC pathway was originally designed to find genetic elements 
regulating the yeast heat-shock stress response.  The authors showed that the 
translation-dependent activation of Hsf1p required the CAT-tailing activity of 
Rqc2p (Brandman et al. 2012).  Yeast deleted for LTN1 contain insoluble protein 
aggregates, indicating a role for RQC in mitigating proteotoxic stress; 
proteotoxicity might also explain why null mutations in Listerin (yeast LTN1) 
cause neurodegeneration in mice (Chu et al. 2009; Choe et al. 2016).  Since heat 
shock can increase the intracellular levels of reactive oxygen species (Bruskov et 
al. 2002), and that ribosomes stall at oxidized sites within the mRNA ORF 
(Simms et al. 2014; Calabretta et al. 2015), such data raise the possibility that 
the RQC pathway could target oxidized mRNA and the associated nascent 
peptide for rapid degradation.  Another study showed that mRNA containing an 
abasic site within the ORF stalled ribosomes and initiated NGD (Gandhi et al. 
2008).  This is consistent with the observation that in vitro translation of abasic 
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mRNA prevents synthesis of full-length proteins (Calabretta et al. 2015).  Finally, 
as mentioned before, UV-irradiation triggers the ribotoxic stress response 
(Iordanov et al. 1998).  Overall, these data point to a model wherein damaged 
RNA might serve as a substrate for translation-dependent quality control. 
 
Current tools to study damaged RNA 
There are a limited number of tools that have been used to detect 
damaged RNA.  Several groups have employed HPLC-MS/MS14 or HPLC-ECD15 
to quantify 8oxoG in total RNA from mammalian tissue samples (Fiala et al. 
1989; Park et al. 1992; Abe et al. 2002; Weimann et al. 2002; Abe et al. 2003; 
Hofer et al. 2006).  These methods are highly sensitive, but require molecular 
standards and several micrograms of nucleic acid (Hofer et al. 2006).  Antibodies 
specific for 8oxoG also exist and have been successfully used for 
immunohistochemistry and competitive ELISA16 (Park et al. 1992; Yin et al. 1995; 
Nunomura et al. 1999; 2002; Shan et al. 2007; Chang et al. 2008; Simms et al. 
2014).  A few studies immunoprecipitated RNA from cells using 8oxoG 
antibodies and performed low- or high-throughput sequencing.  The authors 
																																																						
	
14 High performance liquid chromatography coupled to electrospray tandem mass 
spectrometry  
15 High performance liquid chromatography coupled to electrochemical detection 
16 Enzyme-linked immunosorbent assay 
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identified transcripts that were more susceptible to oxidation in vivo, but did not 
analyze sequence features17 (Shan et al. 2007; McKinlay et al. 2012).  To 
examine methylated RNA, a recently developed method takes advantage of the 
demethylation activity of E. coli AlkB, coined ARM-seq.  By comparing deep-
sequencing results from demethylated and untreated (methylated) RNA, one can 
determine the in vivo methylation landscape (Cozen et al. 2015).   
Many groups have used reverse transcription to detect the presence of 
damaging adducts (Rhee et al. 1995; Iordanov et al. 1998; Gong et al. 2006; 
Hostetter et al. 2012; Kladwang et al. 2012).  Depending on the type of enzyme 
and reaction conditions, reverse transcriptase (RT) tends to stop at modified 
sites, such as adducts formed by UV-irradiation, oxidation, methylation, or 
cisplatin treatment (Iordanov et al. 1998; Gong et al. 2006; Hostetter et al. 2012; 
Wilusz 2015).  Analysis of cDNA products on a sequencing gel reveals prominent 
bands corresponding to RT stops.  This approach has been used to determine 
18S rRNA regions that are prone to cisplatin- or UV-induced adduct formation 
(Iordanov et al. 1998; Hostetter et al. 2012; Kladwang et al. 2012); RT stops also 
revealed oxidized-prone sites on 16S rRNA (Gong et al. 2006).  Nevertheless, 
																																																						
	
17 Regions or motifs within the sequence, such as secondary structures or UTRs.  
For example, if single stranded RNA is more susceptible to oxidation, do regions 
encoding secondary structures exhibit fewer oxidized bases compared to 
unstructured regions?   
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monitoring adduct formation via RT stops is very low-throughput since only one 
sequence can be analyzed at a time.  More recently, however, researchers have 
determined that changing the enzyme and reaction conditions can permit read-
through of modified sites.  For example, the high-processing power of the 
thermostable group II intron reverse transcriptase (TGIRT™) allows for the read-
through of methylated adducts (Mohr et al. 2013; Katibah et al. 2014).  Another 
group determined conditions that allow SuperScript™ II to read through 
SHAPE18-adducts and introduce either a deletion or mutation across the modified 
site.  The authors were able to quantify mutations in the deep-sequencing data to 
determine the secondary structures of several species of RNA (Siegfried et al. 
2014).  This raises the possibility that RT can incorporate mutations across 
damaged sites given the appropriate enzyme and reaction conditions.  If so, one 
can use a deep-sequencing approach to examine sequence features that are 
more susceptible to damaging agents.  Chapter III of this thesis describes the 
development of a deep-sequencing approach to detect oxidized RNA. 
																																																						
	
18 Selective 2'-Hydroxyl Acylation analyzed by Primer Extension (SHAPE) uses 
reagents that preferentially modify RNA 2'-hyroxyls within flexible regions (Merino 
et al. 2005). 
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Abstract 
 
In budding yeast, inactivating mutations within the 40S ribosomal subunit 
decoding center lead to 18S rRNA clearance by a quality control mechanism 
known as nonfunctional 18S rRNA decay (18S NRD).  We previously showed 
that 18S NRD is functionally related to No-Go mRNA Decay (NGD), a pathway 
for clearing translation complexes stalled on aberrant mRNAs.  Whereas the 
NGD factors Dom34p and Hbs1p contribute to 18S NRD, their genetic deletion 
(either singly or in combination) only partially stabilizes mutant 18S rRNA.  Here 
we identify Asc1p (aka RACK1) and Rps3p, both stable 40S subunit 
components, as additional 18S NRD factors.  Complete stabilization of mutant 
18S rRNA in dom34D;asc1D and hbs1D;asc1D strains indicates the existence of 
two genetically separable 18S NRD pathways.  A small region of the Rps3p C-
terminal tail known to be subject to post-translational modification is also crucial 
for 18S NRD.  We combine these findings with the effects of mutations in the 5' 
® 3' and 3' ® 5' decay machinery to propose a model wherein multiple targeting 
and decay pathways kinetically contribute to 18S NRD. 
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Introduction 
 
Accurate and efficient flow of information from nucleic acids to proteins is 
essential for all life.  Central to this process is protein synthesis, which requires 
the coordinated action of myriad components including mRNAs and rRNAs.  As 
with any complex manufacturing process, tight quality control is crucial for both 
ensuring functional products and eliminating defective machine parts.  Therefore, 
numerous mechanisms exist to ensure the overall integrity of the translation 
machinery (Shoemaker and Green 2012).  In eukaryotes, the best understood 
quality control pathways are those that eliminate mRNAs that contain a 
premature stop codon (subject to Nonsense Mediated Decay; NMD) (Amrani et 
al. 2006), lack a stop codon altogether (subject to Non-Stop Decay; NSD) 
(Frischmeyer et al. 2002; van Hoof et al. 2002; Saito et al. 2013b; Horikawa et al. 
2016), or have some structural feature that leads to ribosome stalling (subject to 
No-Go Decay; NGD) (Doma and Parker 2006; Tsuboi et al. 2012).  Each of these 
pathways involves specific factors that recognize and target the defective mRNA 
for degradation by the general mRNA decay machinery.  Decay is often initiated 
via endonucleolytic cleavage of the mRNA at or adjacent to the ribosome stall 
site, followed by 5' ® 3' and 3' ® 5' degradation by Xrn1p and the exosome, 
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respectively (Gatfield and Izaurralde 2004; Doma and Parker 2006; Eberle et al. 
2009; Dimitrova et al. 2009; Tsuboi et al. 2012).  
Other eukaryotic quality control pathways monitor and target rRNA.  
Previous work from our laboratory examined the fate of S. cerevisiae rRNAs 
containing inactivating mutations in either the 18S rRNA decoding center or the 
25S rRNA peptidyl-transferase center (LaRiviere et al. 2006).  These mutant 
rRNAs are synthesized, processed, and assembled into ribosomal subunits 
similarly to wild-type rRNAs.  The functionally-defective mature subunits, 
however, are cleared by mechanistically distinct pathways known respectively as 
18S and 25S Nonfunctional rRNA Decay (18S NRD and 25S NRD).  Large 
ribosomal subunits containing defective 25S rRNAs fail to form stable 80S 
monosomes (LaRiviere et al. 2006) and localize to perinuclear foci (Cole et al. 
2009).  Elimination of these particles by 25S NRD can occur in the absence of 
ongoing translation (Cole et al. 2009), requires the DNA damage repair factors, 
Mms1p and Rtt101p, and involves ubiquitination of 60S subunit proteins (Fujii et 
al. 2009; 2012).  Therefore, 25S NRD appears to occur via a mechanism 
unrelated to mRNA quality control.  In contrast, 18S NRD shares many 
similarities with NGD.  Mutant 18S rRNAs exhibit diffuse cytoplasmic localization 
and co-sediment with 40S subunits, 80S monosomes and, to a lesser extent, 
polysomes (LaRiviere et al. 2006; Cole et al. 2009).  Further, 18S NRD does not 
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occur in the presence of translation elongation inhibitors and is substantially 
reduced in yeast strains lacking the known NGD factors DOM34 and HBS1 (Cole 
et al. 2009).  Structurally related to eRF1 and eRF3, the Dom34p:Hbs1p 
heterodimer recognizes the A-site of stalled ribosomes and functions to both 
dissociate the ribosomal subunits and initiate decay of the associated mRNA 
(Lee et al. 2007; Passos et al. 2009; van den Elzen et al. 2010; Shoemaker et al. 
2010; Becker et al. 2011; Pisareva et al. 2011; Shoemaker and Green 2011; 
Tsuboi et al. 2012; Guydosh and Green 2014; van den Elzen et al. 2014; Hilal et 
al. 2016). 
Whereas translation inhibitors completely abrogate 18S NRD, elimination 
of either DOM34 or HBS1 only slows its kinetics (Cole et al. 2009); therefore, 
additional factors must contribute.  Although we previously demonstrated that 
NMD factors are not required for 18S NRD (Cole et al. 2009), other candidates 
include proteins involved in nascent peptide-dependent translation arrest (PDTA) 
(Dimitrova et al. 2009; Kuroha et al. 2010) or ribosome quality control (RQC) 
(Brandman et al. 2012).  PDTA targets mRNAs containing rare codons or 
encoding stretches of positively charged amino acids, whereas RQC mediates 
the degradation of nascent peptide chains associated with stalled ribosomes.  
One factor known to participate in NGD, PDTA, and RQC is the WD-repeat 
protein Asc1p (Dimitrova et al. 2009; Brandman et al. 2012).  Asc1p (aka RACK1 
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in mammals) is a stoichiometric component of the small ribosomal subunit 
located in the vicinity of the mRNA exit channel (Coyle et al. 2009; Ben-Shem et 
al. 2010).  ASC1 deletion increases the ability of ribosomes to read through rare 
codons and stretches encoding positively charged amino acids (Kuroha et al. 
2010; Brandman et al. 2012; Letzring et al. 2013).  Deletion of ASC1 also 
increases ribosome frameshifting at CGA repeats (Wolf and Grayhack 2015). 
Although these observations led to a model wherein Asc1p somehow promoted 
ribosomal stalling (Kuroha et al. 2010; Inada 2013; Letzring et al. 2013), more 
recent data suggest Asc1p functions instead to target stalled ribosomes for 
quality control (Sitron et al. 2017).  Asc1p may also promote endonucleolytic 
cleavage of NGD substrates (Ikeuchi and Inada 2016). 
Another set of factors implicated in NGD, PDTA and NSD are the Ski 
proteins.  Ski2p, Ski3p, and Ski8p form the Ski complex which binds tightly to 
ribosomes stalled on mRNA 3' ends (van Hoof et al. 2002; Wang et al. 2005; 
Schmidt et al. 2016a).  The central component Ski2p is a DExH-box helicase 
located near the mRNA entrance channel where it is well positioned to feed the 
mRNA 3' end into the exosome (Schmidt et al. 2016a).  Exosome recruitment is 
mediated by Ski7p, which bridges the exosome to Ski3p and Ski8p (Wang et al. 
2005; Kowalinski et al. 2016; Schmidt et al. 2016a).  We previously showed that 
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elimination of SKI7 in combination with HBS1 completely abrogates 18S NRD 
(Cole et al. 2009), but we did not examine the requirement of other Ski proteins. 
The major goal of this study was to identify additional 18S NRD factors 
and elucidate their genetic and mechanistic relationships.  Here we show that 
both ASC1 and SKI2 contribute to the rate of mutant 18S decay, and we identify 
a small region of Rps3p, an essential 40S subunit protein physically residing 
between Asc1p and the mRNA entrance channel, as crucial for 18S NRD.  
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Results 
 
A simplified system for monitoring 18S NRD 
The system we use to monitor 18S NRD employs a galactose-inducible 
(GAL7 promoter) URA+ plasmid encoding the entire 35S pre-rRNA (Figure 2.1, 
A).  Benign sequence tags within the 18S and 25S regions allow for specific 
northern blot detection of plasmid-derived rRNAs, which, when fully induced, 
account for only ~1% of total rRNA in BY4741 yeast (LaRiviere et al. 2006).  
Introduction of an A to C mutation at position 1755 in the decoding center 
(equivalent to A1492C in E. coli 16S rRNA) renders the 40S subunit incapable of 
carrying out efficient elongation and therefore subject to NRD (LaRiviere et al. 
2006; Cole et al. 2009).  Whereas wild-type 18S rRNA (18S:WT) has no 
discernible decay over a six-hour time course (data not shown), mutant 18S 
rRNA (18S:A1492C19) decays with a half-life of <100 minutes (LaRiviere et al. 
2006; Cole et al. 2009).   
																																																						
	
19Although 18S:A1755C would be a more accurate name for this mutation in S. 
cerevisiae, we originally chose to dub it 18S:A1492C in our first NRD paper 
(LaRiviere et al. 2006) to call particular attention to the fact that this position is 
equivalent to E. coli 16S rRNA nucleotide A1492, about which the effects of 
mutations on ribosome decoding were well understood.  In the time since, 
multiple papers using our plasmids have continued to use the 18S:A1492C 
nomenclature (e.g., (Fujii et al. 2009; van den Elzen et al. 2010; Fujii et al. 2012).  
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In previous studies, we monitored 18S NRD by normalizing 18S:A1492C 
to endogenous SCR1 RNA after correcting for cell growth (LaRiviere et al. 2006; 
Cole and LaRiviere 2008; Cole et al. 2009).  However, knowledge that 18S NRD 
is an entirely post-ribosome synthesis process (LaRiviere et al. 2006) raised the 
possibility that the tagged wild-type 25S rRNA (25S:WT) derived from the same 
35S pre-rRNA transcript as 18S:WT or 18S:A1492C might be a better (or at least 
equivalent) normalization control.  An added advantage of normalizing tagged 
18S to tagged 25S:WT is that there is no need to correct for cell growth or 
variable plasmid copy number.  To test the reliability of this 18S:25S ratio 
approach, we grew parental BY4741 yeast harboring either the 18S:WT or 
18S:A1492C plasmid (both paired with 25S:WT) to mid-log phase in synthetic 
complete minus uracil media (SC-ura) plus raffinose, induced tagged pre-rRNA 
expression for 90 minutes with galactose, turned off transcription by adding 
glucose, then collected samples over time (Figure 2.1, B).  Our results 
demonstrate that normalizing tagged 18S:WT or 18S:A1492C to the tagged 
25S:WT yielded similar findings as normalizing to endogenous SCR1 RNA.  That 
is, whereas there was no apparent decay of 18S:WT, 18S:A1492C had a half-life 
of 76 minutes in the parental strain (Figure 2.1, B and 2.2, B).  The 18S:25S 
																																																						
	
Therefore, to avoid compounding any confusion, we will retain the 18S:A1492C 
nomenclature here. 
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ratio also reproduced previous findings that individual deletion of either DOM34 
or HBS1 resulted in partial 18S:A1492C stabilization (Figure 2.1, B) (Cole et al. 
2009). 
Because time courses are inherently low throughput, we also tested the 
feasibility of monitoring a single time point.  After inducing expression for 90 
minutes, cells were immediately harvested and subjected to northern analysis.  
As expected, 18S:A1492C was substantially lower than 18S:WT in the parental 
BY4741 yeast, with the decrease being less drastic, but still statistically 
significant (p = 0.0022, unpaired t test), in the dom34D strain (Figure 2.1, D).  
Thus, a single-time point assay proved sufficient as an initial mutant screen.   
 
DOM34 paralogs are not involved in 18S NRD 
Whereas deletion of DOM34, HBS1, or both slows 18S:A1492C decay, 
small molecule translation inhibitors completely abrogate decay (Cole et al. 
2009); this suggests the existence of a second, kinetically separable 18S NRD 
pathway.  Consistent with the multiple-pathway hypothesis, we previously 
showed that double deletion of HBS1 and SKI7 completely stabilizes 
18S:A1492C (Figure 2.1, C) (Cole et al. 2009).  Since Hbs1p and Dom34p form 
a heterodimer and their simultaneous deletion had no additive effect on 18S NRD 
(Cole et al. 2009), we reasoned that double deletion of DOM34 and SKI7 would 
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also completely stabilize 18S:A1492C.  Unexpectedly, however, no synthetic 
effect was apparent in the dom34D;ski7D strain (Figure 2.1, C and 2.4).  One 
possible explanation for this result was the existence of a cross-functional 
Dom34p paralog.  Dom34p consists of three domains: N (1-131 aa), M (136-268 
aa), and C (271-370 aa), with M and C serving as the binding sites for Hbs1p 
(Chen et al. 2010; van den Elzen et al. 2010). S. cerevisiae contains two genes 
of unknown function, YCL001W-A and YCL001W-B, and a multiple sequence 
alignment showed both having high similarity with the M and C domains of 
Dom34p (data no shown).  However, no decrease in 18S NRD efficiency was 
observed in either a YCL001W-A or YCL001W-B knockout strain, and when 
either deletion was combined with the DOM34 deletion, there was no 
enhancement of the dom34D phenotype (Figure 2.1, E).  Thus, we conclude that 
neither YCL001W-A nor YCL001W-B contribute to 18S NRD.   
 
Asc1p contributes to 18S NRD 
To identify additional 18S NRD factors, we performed a small screen in 
strains lacking proteins previously implicated in other degradation pathways 
(Figure 2.1, F).  Among these, only the ASC1 knockout diminished 18S NRD 
(Figure 2.1, F and 2.2, A). Substantially more 18S:A1492C was observed in the 
asc1D strain than the parental strain, with the level being comparable to the 
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dom34D strain.  In the dom34D;asc1D double-deletion strain, 18S:A1492C levels 
were indistinguishable from 18S:WT (Figure 2.2, A).  Time course data 
confirmed that, whereas deletion of either ASC1 or DOM34 alone resulted in a 
two-fold increase in 18S:A1492C half-life, deletion of both led to its complete 
stabilization (Figure 2.2, B).  ASC1 was also synthetic with HBS1 (Figure 2.4), 
and in no strain was 18S:WT detectably degraded (Figure 2.2, B and 2.4).  
Although the dom34D;asc1D and hbs1D;asc1D strains grew more slowly than the 
parental strain, neither grew more slowly than the asc1D single deletion strain 
(Figure 2.3, B).  Therefore, slower cell growth could not account for the observed 
synthetic effects. 
To confirm that the 18S NRD defect observed in the asc1D strain was due 
to the loss of the ASC1 protein and not the snR24 snoRNA that derives from the 
ASC1 intron, we transformed the asc1D strain with different plasmids containing 
the ASC1 gene with or without the intron, both under control of the endogenous 
ASC1 promoter.  The intron-less version completely restored 18S NRD (Figure 
2.2, C).  Further, when transformed into the parental strain, neither plasmid 
enhanced 18S:A1492C decay.  Thus, we conclude that Asc1p is an 18S NRD 
factor, and its endogenous levels are sufficient for optimal 18S NRD. Taken 
together, these data indicate the existence of two genetically separable pathways 
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contributing to 18S NRD kinetics:  one involving DOM34 and HBS1, and another 
involving ASC1.   
 
Increased non-functional 80S monosomes in dom34D;asc1D lysates 
In a wild-type background, 18S:A1492C rRNA predominantly co-
sediments on sucrose gradients with 40S subunits (Figure 2.3, A) (LaRiviere et 
al. 2006).  This suggests highly efficient resolution of stalled 80S monosomes 
containing the 18S:A1492C mutation.  Since both Asc1p and Dom34p have been 
implicated in targeting and resolving stalled ribosomes (Shoemaker et al. 2010; 
Tsuboi et al. 2012; Sitron et al. 2017), we next examined sucrose gradients of 
asc1D, dom34D, and dom34D;asc1D.  The sedimentation pattern in asc1D 
lysates revealed a slight increase in the amount of 18S:A1492C co-sedimenting 
with 80S monosomes, and this increase was more noticeable in dom34D lysates. 
This effect was further amplified in the dom34D;asc1D double-mutant (Figure 
2.3, A).  While there was some increase in bulk 80S monosomes in both the 
dom34D and dom34D;asc1D profiles (data not shown), this increase was much 
less pronounced than the change in 80S co-sedimentation of 18S:A1492C in the 
dom34D;asc1D lysate (Figure 2.3, A).  Thus, cells lacking both ASC1 and 
DOM34 are substantively impaired in their ability to resolve non-functional 80S 
ribosomes.  
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Variable effects of Ski proteins on 18S NRD 
Having identified a new ASC1-dependent pathway contributing to 18S 
NRD, we next tested whether ASC1 was synthetic with SKI7.  However, we could 
detect no difference in the rate of 18S:A1492C decay between the asc1D single 
deletion and asc1D;ski7D double deletion strain (Figure 2.4).  To investigate 
whether the Ski complex itself contributes to 18S NRD, we examined 
18S:A1492C decay kinetics in ski2D strains (Figure 2.4).  Deletion of SKI2 alone 
had no effect on cell doubling time (Figure 2.3, B), but it slowed 18S:A1492C 
decay to a similar extent as deletion of either DOM34 or ASC1 alone.  No further 
decrease in decay rate was observed, however, in either a dom34D;ski2D or 
asc1D;ski2D strain (Figure 2.4) despite decreased growth rates of these double 
mutant strains (Figure 2.3, B).  Thus, while both SKI7 and SKI2 contribute to the 
rate of 18S:A1492C decay, neither is synthetic with DOM34 or ASC1.  Further, 
there is no clear relationship between cell doubling time and the rate of 
18S:A1492C decay. 
 
The Rps3p C-terminal tail 
On the ribosome, the binding sites for Dom34p:Hbs1p and Asc1p are 
separated by >75 angstroms (Becker et al. 2011; Hilal et al. 2016).  Whereas 
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Dom34p:Hbs1p interact with the A-site at the interface between the large and 
small subunits, Asc1p resides on the opposite (solvent-exposed) surface of the 
small subunit in the general area of the mRNA exit channel.  Physically linking 
these two sites is a single protein: Rps3p (Figure 2.5, A).  The body of Rps3p 
consists of an N-terminal type II KH domain (three-stranded b-sheet backed by 
three a-helices; amino acids 1-88) attached via a nine-amino acid linker to a 
central RRM-like domain (four-stranded b-sheet backed by two a-helices; amino 
acids 98-189); together these form part of the mRNA entrance channel adjacent 
to the A-site.  Intriguingly, cryo-EM studies indicate that the body of Rps3p 
contacts the N-terminal 90-amino acid globular domain of Hbs1p, which is 
attached via a 62-amino acid flexible linker to the GTPase core (Becker et al. 
2011; Hilal et al. 2016).  A 50-amino acid C-terminal tail extends from the body of 
Rps3p along the outer surface of the small ribosomal subunit and contacts the 
fourth WD repeat in Asc1p (Ben-Shem et al. 2010).  This network of structural 
contacts between Hbs1p, Rps3p, and Asc1p suggested to us that RPS3 might be 
a component of the 18S NRD pathway.   
 Because RPS3 encodes an essential protein, it was impossible to monitor 
18S NRD in an RPS3 knockout strain.  We therefore implemented a 5-FOA 
plasmid shuffle approach in a rps3D background to test the effects of various 
rps3 mutations (Figure 2.5, B and 2.6, A).  Validating this approach, a LEU+ 
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plasmid encoding wild-type RPS3 complemented the knockout strain, whereas 
the empty LEU+ vector did not.  For point mutations, we chose positions that 
were highly conserved across all eukaryotes (data not shown) and were 
previously proposed to make specific interactions with the Hbs1p N-terminal 
domain (Figure 2.5, A) (Becker et al. 2011).  All point mutations tested 
complemented the rps3D strain, indicating that none of the amino acids we 
mutated were required for viability.  All four mutations also had 
18S:A1492C/25:WT ratios similar to wild-type RPS3 (Figure 2.5, B), suggesting 
that the mutations fail to compromise the interaction between Rps3p and Hbs1p 
or that the interaction might be dispensable for 18S NRD. 
 To more rigorously test the functionality of the Rps3p:Hbs1p interaction, 
we next mutated HBS1.  Earlier work had shown that an hbs1 protein variant 
lacking the entire N-terminal domain (amino acids 1-152) retains its ability to bind 
to ribosomes in complex with Dom34p (Becker et al. 2011).  When we 
complemented the hbs1D strain with plasmids encoding either full-length HBS1 
(1-611) or hbs1 lacking either the first 90 or 152 amino acids (hbs11-90∆ and 
hbs11-152∆, respectively), we observed no difference in the rate of 18S:A1492C 
decay (Figure 2.5, C).  Therefore, we conclude that the interaction of the Hbs1p 
N-terminus with Rps3p is dispensable for 18S NRD. 
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We next examined the Asc1p:Rps3p interaction.  The Rps3p C-terminal 
tail (amino acids 190-240) exhibits much lower sequence conservation than the 
N-terminal domains (data not shown).  To test the essentiality of the tail, we 
made a series of C-terminal truncation mutants.  Whereas rps31-200 proved 
inviable, cells expressing either rps31-211 or rps31-217 grew equally well as cells 
expressing full-length RPS3 (amino acids 1-240) (Figure 2.3, B and 2.6, A).  
Thus, amino acids 1-211 of S. cerevisiae Rps3p are sufficient for both survival 
and wild-type cell growth.  We did, however, observe a significant difference 
between the two truncation mutants with regard to 18S NRD efficiency: whereas 
yeast expressing rps31-217 degraded 18S:A1492C at a rate indistinguishable from 
cells expressing the full-length protein, 18S:A1492C decay in rps31-211 yeast was 
>11-fold slower (Figure 2.6, B).  The magnitude of this effect is so far the largest 
we have observed for any single mutation or gene deletion tested (this study) 
(Cole et al. 2009).  Thus, a small region of the Rps3p C-terminal tail is crucial for 
efficient 18S NRD.  Of the six amino acids (KEEEPI), the first three (KEE) are 
highly conserved across eukaryotic species (Figure 2.6, C).   
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Discussion 
 
 Here we identified Asc1p, Ski2p, and Rps3p as factors contributing to 
18S:A1492C rRNA decay kinetics.  We found that ASC1 is synthetic with DOM34 
and HBS1, but not with SKI7 (Figure 2.2, B and 2.4).  Further, whereas deleting 
SKI2 slowed 18S:A1492C rRNA decay similarly to deletion of ASC1, DOM34, or 
HBS1, no synthetic effects were detectable upon combining a SKI2 deletion with 
deletion of ASC1 or DOM34 (Figure 2.4).  Finally, we found that mutant 18S 
rRNA is substantially stabilized upon deletion of a six-amino acid region within 
the C-terminal tail of Rps3p (Figure 2.6, B), implicating Rps3p as a central player 
in targeting nonfunctional 40S subunits for preferential elimination by 18S NRD.  
We synthesize these findings with previous data to propose a model wherein 18S 
NRD is the result of multiple independent targeting and decay pathways (Figure 
2.7). 
  
18S NRD, NGD, PDTA and RQC:  Different outcomes of ribosome stalling 
The data in this paper strengthen and extend our previous findings that 
18S NRD is functionally related to the mRNA and protein quality control 
pathways associated with ribosome stalling (this study) (Cole et al. 2009).  NGD, 
PDTA, 18S NRD, and RQC were all discovered independently by examining the 
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fate of mRNAs (NGD and PDTA) or rRNAs (18S NRD) with features that inhibit 
protein production, or by a genome-wide screen for deletions that over-activate 
the heat-shock stress response pathway (RQC) (Doma and Parker 2006; 
LaRiviere et al. 2006; Cole et al. 2009; Dimitrova et al. 2009; Kuroha et al. 2010; 
Brandman et al. 2012).  Subsequent investigation of the identified RQC genes 
led to the finding that this increased stress response was due to accumulation of 
aberrant nascent peptides associated with stalled ribosomes (Brandman et al. 
2012; Choe et al. 2016).  Evidence accumulating since these initial discoveries 
suggests that all four pathways are simply alternate outcomes of the same 
initiating event – a stalled or slowly elongating ribosome (Shoemaker and Green 
2012; Brandman and Hegde 2016).  Whether an individual stall event leads to all 
or only a subset of these outcomes may depend on both the nature of the stall 
and the kinetic stability of the stalling event (i.e., whether the ribosome is 
completely halted or is simply moving slowly).   
A recently proposed unifying model (Brandman and Hegde 2016) 
suggests the following order of events for the resolution of stalled ribosomes:  (1) 
recognition and targeting of the stalled ribosome by Asc1p, Hel2p (an E3 
ubiquitin ligase), and the recently identified RQT complex (Brandman et al. 2012; 
Sitron et al. 2017; Matsuo et al. 2017); (2) subunit dissociation by Dom34p, 
Hbs1p, and Rli1p (mammalian ABCE1) (Shoemaker et al. 2010; Shoemaker and 
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Green 2011; Pisareva et al. 2011; Tsuboi et al. 2012); (3) degradation of the 
associated aberrant mRNA (Frischmeyer et al. 2002; van Hoof et al. 2002; Doma 
and Parker 2006; Tsuboi et al. 2012); (4) assembly of the remaining RQC 
components onto the 60S subunit (Brandman et al. 2012; Shao et al. 2015); (5) 
CAT-tailing by Rqc2p and/or ubiquitination of the nascent peptide chain by Ltn1p 
(another E3 ubiquitin ligase) (Bengtson and Joazeiro 2010; Shao and Hegde 
2014; Shen et al. 2015; Shao et al. 2015; Osuna et al. 2017); and (6) extraction 
and degradation of the ubiquitinated nascent peptide (Brandman et al. 2012; 
Defenouillère et al. 2013; Verma et al. 2013; Kostova et al. 2017; Osuna et al. 
2017).  Missing from this model is the fate of the 40S subunit.  In cases where 
ribosome stalling was not due to any specific 40S dysfunction, it would seem 
reasonable that the subunit would simply be released to return to the 
translationally active pool.  However, when stalls are due to a specific 40S defect 
(such as the decoding center mutation used here), the defective subunit is 
ultimately dismantled and the 18S rRNA decayed.  Since ASC1 and 
DOM34:HBS1 are additive for 18S:A1492C kinetics (Figure 2.2, B and 2.4), our 
data suggest that initial targeting of the 40S subunit for decay occurs prior to or 
concurrent with 80S ribosome dissociation.  However, the lack of an 18S NRD 
defect in the ltn1D strain (Figure 2.1, F) suggests that the 40S subunit fate is not 
tied to the process of dismantling of the nascent peptide-60S complex. 
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Multiple kinetic contributors to 18S NRD targeting and decay 
While we were successful in identifying additional 18S NRD factors 
(Asc1p, Rps3p, and Ski2p), some of the single- and double-mutant results were 
confounding.  For example, while the deletion of SKI2 partially stabilizes mutant 
18S rRNA, it is not synthetic with either DOM34 or ASC1 (Figure 2.4). 
Furthermore, whereas a HFY1200 strain lacking XRN1 exhibits decreased 18S 
NRD kinetics, this same deletion in a BY4741 background is without apparent 
consequence (Cole et al. 2009).  Finally, we previously observed no substantial 
decrease in 18S NRD kinetics in a temperature-sensitive exosome strain (Cole et 
al. 2009).  To explain these apparent inconsistencies, we propose a model 
wherein multiple parallel and sequential pathways kinetically contribute to 18S 
NRD (Figure 2.7).  In this model, Asc1p and the Dom34p:Hbs1p heterodimer sit 
at the top of the pathway where they function independently to target non-
functional 40S subunits for decay.  Once targeted, 18S rRNA decay likely 
involves subunit disassembly and both endonucleolytic and exonucleolytic 
activities, with the relative kinetic contributions of 5' ® 3' decay by Xrn1p and 3' 
® 5' decay by the exosome being highly dependent on strain background and 
growth conditions (Cole et al. 2009).  
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Whereas the half-lives of NGD, NSD, and PDTA mRNAs range from 2 to 9 
minutes in wild-type yeast (Frischmeyer et al. 2002; Doma and Parker 2006; 
Tsuboi et al. 2012; Sweet et al. 2012), the half-life of 18S:A1492C rRNA ranges 
from 41 to 96 minutes (this study) (LaRiviere et al. 2006; Cole et al. 2009).  Since 
the 18S:A1492C half-lives are of similar magnitude to the doubling time of wild-
type yeast (87 minutes), a simple explanation could have been that 18S NRD is 
somehow tied to the cell cycle. However, we observed no consistent relationship 
between 18S:A1492C decay kinetics and cell growth rate over multiple strain 
backgrounds (Figure 2.3, B).  What can account for the 10-fold slower kinetics of 
18S NRD compared to defective mRNA decay? Is 18S NRD targeting slow, with 
non-functional 40S subunits going through multiple rounds of initiation prior to 
being tagged for decay, or is targeting efficient and decay slow?  What steps are 
involved in decay?  Does decay first require 40S disassembly (i.e., removal of 
some or all of the proteins) to allow for 18S rRNA decay, or is 18S rRNA decay 
initiated within the intact subunit with protein disassembly occurring concomitant 
with rRNA degradation?  While the available data do not address these questions 
directly, the observation of no 18S:A1492C decay in the presence of elongation 
inhibitors (Cole et al. 2009) suggests that targeting of non-functional 40S 
subunits to 18S NRD is relatively inefficient and may require multiple rounds of 
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initiation.  Slow targeting would also be consistent with the variable kinetic effects 
of eliminating individual components of the degradation machinery. 
 
A central role for RPS3 
Rps3p (a.k.a. uS3 in the recently adopted systematic ribosomal protein 
nomenclature (Ban et al. 2014)) is an essential component of the small ribosomal 
subunit.  Along with Rps2p (uS5) and Rps30p (eS30), Rps3p forms part of the 
mRNA entrance channel (Ben-Shem et al. 2010).  The type II KH and RRM-like 
domains of Rps3p are structurally conserved from bacteria to humans, whereas 
the C-terminal tail is more conserved in eukaryotes (data not shown).  
Proteomics studies in S. cerevisiae have identified C-terminal tail amino acids 
K200, T207, K212, S221, and T231 as sites of acetylation, phosphorylation, 
succinylation, and/or ubiquitination (Peng et al. 2003; Albuquerque et al. 2008; 
Seyfried et al. 2008; Holt et al. 2009; Soulard et al. 2010; Weinert et al. 2013; 
Fang et al. 2014).  If 18S NRD consists of independent targeting and decay 
pathways, then post-translation modification of the Rps3p tail could serve as the 
mark that connects targeting to decay.  Indeed, the significant decrease in 
18S:A1492C rRNA half-life (>11-fold) observed upon removing Rps3p amino 
acids 212-217 (Figure 2.6, B) suggests a central role for one or more of these 
residues. 
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In S. cerevisiae, Drosophila, and human ribosomes, the Rps3p/RPS3 tail 
interacts with the WD40 blade IV of Asc1p/RACK1 (Ben-Shem et al. 2010; Anger 
et al. 2013), but functional relevance had been lacking.  Recent studies in 
mammalian cells investigating ribosome read-through on poly(A) stretches now 
suggest a regulatory link between Asc1p and Rps3p (Sundaramoorthy et al. 
2017; Juszkiewicz and Hegde 2017).  RACK1 (yeast ASC1) and ZNF598 (yeast 
HEL2) are both involved in ubiquitination of stalled ribosomes (Saito et al. 2015; 
Sundaramoorthy et al. 2017; Juszkiewicz and Hegde 2017).  HEL2 was 
previously identified as a genetic component of the S. cerevisiae RQC pathway 
where it, along with ASC1, acts upstream of LTN1 (Brandman et al. 2012; 
Letzring et al. 2013; Sitron et al. 2017).  Both mammalian ZNF598 and RACK1 
facilitate RPS3 (uS3) ubiquitination, although ZNF598 primarily participates in 
RPS10 (eS10) and RPS20 (uS10) ubiquitination, whereas RACK1 primarily 
participates in RPS2 (uS5) and RPS3 ubiquitination.  Furthermore, inhibitors of 
translation elongation and activators of the unfolded protein response pathway 
also result in RPS3 ubiquitination, with the ubiquitination site occurring on the 
yeast equivalent of K212 (Higgins et al. 2015; Sundaramoorthy et al. 2017; 
Juszkiewicz and Hegde 2017).  Another recent study showed that yeast Hel2p 
ubiquitinates both Rps20p (uS10) K6/K8 and Rps3p K212 in stalled ribosomes 
(Matsuo et al. 2017).  Collectively, these findings may explain why loss of ASC1 
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only partially stabilizes 18S:A1492C, whereas deletion of RPS3 amino acids 212-
217 has a much stronger effect.  It seems likely that Asc1p and Hel2p converge 
to ubiquitinate Rps3p K212, which in turn serves to target the mutant 18S rRNA 
for decay. 
 
Multiple pathways for resolving stalled ribosomes across domains 
The existence of multiple pathways in eukaryotes for detecting and 
eliminating functionally defective ribosomes parallels the situation in prokaryotes.  
Although the decoding center A1492C and G530U mutations are known to 
inactivate the 16S rRNA decoding center (Powers and Noller 1990; 1993; 
Yoshizawa et al. 1999a; Ogle et al. 2001), these mutant rRNAs are not subject to 
preferential degradation in E. coli (Paier et al. 2015).  Nonetheless, E. coli does 
harbor three functionally redundant pathways for rescuing ribosomes stalled on 
truncated mRNAs:  the trans-translation pathway, ArfB, and ArfA (Keiler et al. 
1996; Karzai et al. 1999; Chadani et al. 2011b; 2010).  In the trans-translation 
pathway, tmRNA/SmpB recognizes the empty A-site and acts as both a tRNA 
and mRNA to allow continued elongation and normal termination at the tmRNA 
stop codon.  ArfB and ArfA act as backups to the tmRNA/SmpB system.  ArfB, a 
release factor 2 (RF2) homolog, binds to the stalled ribosome and initiates 
peptidyl-tRNA hydrolysis and ribosome release.  ArfA accomplishes the same 
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thing, but does so by binding within the empty mRNA channel and directly 
recruiting RF2 to the A-site.  Of particular note for our findings, the ArfA and ArfB 
pathways were discovered only upon tmRNA/SmpB inactivation (Chadani et al. 
2010; 2011b).  The existence of so many redundant mechanisms in bacteria to 
rescue stuck ribosomes suggests that ribosome stalling is a pervasive problem.  
Indeed, it has been estimated that 2-4% of all translating ribosomes in E. coli are 
in need of rescue at any given time (Ito et al. 2011; Keiler 2015).  Given the 
greater complexity of their translation machinery, one might predict ribosome 
stalling to be even more problematic in eukaryotes. Thus, it would not be 
surprising if more pathways for resolving stalled translation complexes await 
discovery.  
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Methods and Materials 
 
Yeast Strains and Plasmids: 
All strains and plasmids used in this study are listed in Table 2.1.  The 
dom34∆;asc1∆, hbs1∆;asc1∆, asc1∆;ski7∆, and asc1∆;ski2∆ mutants were 
constructed by transforming a dom34∆, hbs1∆, ski7∆, or ski2∆ strain with dsDNA 
encoding asc1∆::NATMX and colony selection on G418;ClonNat plates.  The 
dom34∆;ski7∆ and dom34∆;ski2∆ mutants were constructed by transforming a 
ski7∆ or ski2∆ strain with dsDNA encoding dom34∆::NATMX and colony 
selection on G418;ClonNat plates. Homologous recombination at the ASC1 or 
DOM34 locus was confirmed by PCR.  rps3 mutant strains were constructed by 
plasmid shuffling.  Briefly, a RPS3/rps3∆::KANMX diploid strain was transformed 
with a RPS3/URA3+ plasmid, sporulated, and selected on SC-ura;G418 plates to 
obtain a haploid rps3∆::KANMX strain harboring the URA3+ plasmid.  LEU2+ 
plasmids encoding rps3 variants were then transformed into the 
rps3∆::KANMX;URA3+ haploid strain; rps3 variants that had lost the URA3+ 
plasmid were then selected on SC-leu;5-FOA plates.  To generate hbs1 N-
terminal deletion strains, a hbs1∆ haploid strain was transformed with plasmids 
encoding either HBS1, hbs11-90∆, or hbs11-152∆; all variants were expressed under 
the endogenous HBS1 promoter. 
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Single Time Point Assay: 
Strains harboring pSC40-WT (18S:WT;25S:WT) or pSC40-A1492C 
(18S:A1492C;25S:WT) plasmids were grown at 30°C in SC-ura media plus 2% 
raffinose to mid-log phase (OD600 = 0.4-0.5).  Following addition of 20% 
galactose (final concentration = 2%) to induce rRNA transcription, cells were 
incubated at 30°C for an additional 90 minutes.  Pre-warmed SC-ura media plus 
2% galactose was added as necessary to maintain OD600 = 0.5.  Cells were 
then harvested by centrifugation and flash frozen in liquid nitrogen or a dry 
ice/EtOH mixture. 
 
Pulse-chase Analysis: 
Pulse-chase analysis was performed as previously described (Cole and 
LaRiviere 2008) with some modifications.  Strains harboring pSC40-WT or 
pSC40-A1492C plasmids were grown at 30°C in SC-ura media plus 2% raffinose 
to mid-log phase (OD600 = 0.4-0.5).  20% galactose was added to a final 
concentration of 2% to induce rRNA transcription, and cells were incubated for 
an additional 90 minutes.  50% glucose was then added to a final concentration 
of 2% and the first-time point (T=0) was immediately harvested; subsequent time 
points were taken at indicated intervals post glucose addition.  Samples were 
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pelleted by centrifugation, and then flash frozen in liquid nitrogen or a dry 
ice/EtOH mixture.  Pre-warmed SC-ura media plus 2% glucose was added as 
necessary to maintain an OD600 of 0.5 for the duration of the time course. 
 
Northern Blot Analysis: 
For each sample, 2.0-2.5 μg total RNA was electrophoresed on a 1% agarose-
formaldehyde gel and transferred to a nitrocellulose membrane as previously 
described (Cole and LaRiviere 2008; Cole et al. 2009).  Total RNA was detected 
via staining with Methylene Blue (Molecular Research).  Membranes were 
hybridized with 32P-end-labeled probes FL125 (anneals to plasmid-derived 18S 
rRNA) and FL126 (anneals to plasmid-derived 25S rRNA) for 12-24 hours at 
42°C in ExpressHyb (BD Biosciences).  Bands were visualized using a Typhoon 
Phosphorimager (Molecular Dynamics) and quantified via ImageQuant software 
(GE Lifesciences).  Signal from the tagged-18S rRNA was normalized to the 
signal from the tagged-25S rRNA. Curve fitting was done using GraphPad Prism 
7 software. 
 
Sucrose Gradients: 
The parental wild-type, dom34Δ, asc1Δ, and dom34Δ;asc1Δ strains were 
transformed with the pSC40-A1492C plasmid and grown to mid-log in SC-ura 
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media plus 2% raffinose (80 mL culture volume per gradient). After a 90-minute 
induction with 2% galactose, cycloheximide was added to a final concentration of 
0.1 mg/mL. Cells were immediately chilled on ice, harvested, and lysed in the 
presence of glass beads and lysis buffer (20 mM Tris-HCl pH=8.0, 140 mM KCl, 
1.5 mM MgCl2, 0.5 mM DTT, 1% Triton X-100, 0.1 mg/mL cycloheximide, 1 
mg/mL heparin). Individual lysates (12 A260 units) were layered onto 5-47% 
sucrose gradients (sucrose, 20 mM Tris-HCl pH=8.0, 140 mM KCl, 5mM MgCl2, 
0.5 mM DTT, 0.1 mg/mL cycloheximide, 0.5 mg/mL heparin) and spun in an 
ultracentrifuge (35K rpm, 160 minutes, SW41 rotor). Individual fractions were 
then collected and subjected to northern blot analysis. 
 
Multiple Sequence Alignments: 
A multiple sequence alignment of the DOM34, YCL001W-A, or YCL001W-B 
protein sequences was performed using ClustalW (v1.83). A multiple sequence 
alignment of RPS3 protein sequences across various species (from E. coli to H. 
sapiens) was also performed using ClustalW (v1.83). 
 
Supplemental Material 
Supplemental material includes a table of yeast strains, plasmids, and probe 
sequences used in this study. 
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Figure 2.1: System for studying 18S NRD 
(A) Diagram of rDNA plasmid reporter (top) and summary of experimental design 
(bottom).  The reporter contains sequence tags for northern blot detection of 
plasmid-derived 18S and 25S rRNAs. (B) Time course analysis of tagged 18S 
and 25S rRNAs in parental, dom34∆, and hbs1∆ yeast strains.  (C) Same as (B), 
but for dom34∆, ski7∆, dom34∆;ski7∆, and hbs1∆;ski7∆ strains.  (B and C) 
Tagged 18S:tagged 25S ratios (18S/25S) were normalized to the T=0 time point; 
error bars represent standard error of the mean (n=3). 18S:A1492C half-life is 
indicated on the right. (D, E, and F) Single time-point analyses of tagged 18S 
rRNAs. Error bars represent standard error of the mean (n=3).  (D) Unpaired t 
test was used for significance testing against parental strain 18S:A1492C levels.  
(E) One-way ANOVA with planned comparisons was used for significance testing 
comparing 18S/25S in parental strain to single mutants or in dom34∆ strain to 
double mutants.  ns = not significant. (F) One-way ANOVA with planned 
comparisons was used for significance testing comparing 18S/25S in all mutant 
strains against the parental strain. 
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Figure 2.2: ASC1 contributes to 18S NRD 
(A) Single time-point analysis of tagged 18S and 25S rRNAs. One-way ANOVA 
with planned comparisons was used for significance testing comparing the 
parental strain and each single deletion 18S:A1492C/25S:WT ratio.  Unpaired t 
test was used to compare the parental strain and dom34∆;asc1∆ 
18S:A1492C/25S:WT ratios.  Error bars represent standard error of the mean 
(n=3).  (B) Time course analysis of 18S:A1492C and 18S:WT decay in dom34∆ 
and asc1∆ single and double deletion strains.  Representative northern blots of 
tagged 18S:A1492C and 25S rRNAs and graphs summarizing multiple (n=3) 
biological replicates.  Normalization and error bars as in Figure 2.1 B and C.  (C) 
Single time-point analysis of tagged 18S:A1492C rRNA in parental and asc1∆ 
strains harboring indicated plasmids.  One-way ANOVA with planned 
comparisons was used for significance testing of all strains against the “Parental 
strain + empty vector” strain.  Error bars represent standard error of the mean 
(n=3). 
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Figure 2.3: Polysome profiles and growth rates 
(A) Polysome profiles.  Top:  Representative sucrose gradient trace for the 
parental strain.  Bottom: Methylene Blue stains and Northern blots of sucrose 
gradient fractions for the parental, asc1∆, dom34∆, and asc1∆;dom34∆ strains 
harboring the 18S:A1492C plasmid.  Boxes show positions of 40S, 60S and 80S 
ribosomes.  (B) Scatter plot of mean 18S:A1492C half-lives (n=3) versus mean 
growth rates (doubling time; n=3) of various yeast strains used in current study. 
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Figure 2.4: Variable effects of Ski proteins on 18S NRD 
Time course analysis of 18S:A1492C and 18S:WT in single and double deletion 
strains.  Representative northern blots of tagged 18S:A1492C and 25S rRNAs 
and graphs summarizing multiple (n=2-3) biological replicates.  Normalization 
and error bars as in Figure 2.1 B and C.  18S:A1492C data from the parental and 
asc1∆ single deletion strains are the same as Figure 2.1 B (parental) and Figure 
2.2 B (asc1∆). 
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Figure 2.5: Hbs1p N-terminal domain is dispensable for 18S NRD 
(A) Left: Cryo-EM structure of the yeast 80S ribosome in complex with 
Dom34p:Hbs1p (orange:red), P-site tRNA (yellow), and nonstop mRNA (black) 
(PDB: 5M1J) (Hilal et al. 2016).  Also highlighted are Asc1p (green) and Rps3p 
(purple).  Right: Close up of the Hbs1p:Rps3p:Asc1p interaction.  Positions of 
Rps3p point mutations at the Hbs1p:Rps3p interface are shown in yellow.  Note 
that amino acids 3-225 of Rps3p have been resolved (Full-length: 240).  (B) Left: 
Plasmid shuffle experiment showing growth of strains (10-fold dilution series) 
harboring plasmids expressing wild-type RPS3 or indicated point mutations on a 
LEU-URA- or LEU-5-FOA plate.  Right: Single time-point analyses of tagged 18S 
and 25S rRNAs.  For all strains, 18S:A1492C/25S:WT ratio was normalized to 
the 18S:WT/25S:WT ratio.  Error bars represent standard error of the mean.  
One-way ANOVA with planned comparisons was used for significance testing 
comparing all rps3 variant strains against the wild-type RPS3 strain; only rps31-211 
was statistically different (p<0.0001).  (C) Diagram of Hbs1p domains (top) and 
time course analysis of 18S:A1492C in hbs1 strains (bottom).  Data 
normalization as in Figure 2.1 B and C.  Representative northern blots and graph 
of time course data with indicated 18S:A1492C rRNA half-lives.  Error bars 
represent standard error of the mean (n=2). 
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Figure 2.6: Rps3p C-terminal tail is crucial for 18S NRD 
(A) Plasmid shuffle experiment showing growth of strains (10-fold dilution series) 
harboring plasmids expressing wild-type RPS3 or indicated C-terminal truncation 
variant on a LEU-URA- or LEU-5-FOA plate.  (B) Time course analysis of 18S 
rRNA in rps3 yeast strains.  Representative northern blots of tagged 18S and 
tagged 25S rRNA and graphs summarizing multiple (n=3) biological replicates.  
Normalization and error bars as in Figure 2.1 B and C.  (C) Multiple sequence 
alignment of RPS3 protein sequences.  
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Figure 2.7: Current model of 18S NRD 
Proposed model depicting the contributions of multiple independent targeting and 
decay pathways to 18S NRD.  A stalled ribosome harboring mutant 18S rRNA 
(blue splatter) can be marked for decay by two separate pathways involving 
either Asc1p or Dom34p:Hbs1p.  Once marked (possibly by covalent modification 
of the Rps3p C-terminal tail), 40S ribosomes are disassembled and 18S rRNA 
degraded by 5' ® 3' and 3' ® 5' decay pathways. 
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CHAPTER III.  A deep-sequencing approach to detect oxidized RNA 
 
 
 
Melissa J. Moore, Ph.D., and I designed the study.  I performed the reverse 
transcription experiments and prepared libraries for the 40mer oligos, 8oxoG 
oligos, and in vitro synthesized RNA.  I also performed the yeast experiments 
and prepared libraries from yeast total RNA.  Hakan Ozadam, Ph.D., processed 
the synthesized RNA dataset while I processed the yeast dataset.  Nicholas 
Hathaway wrote the mutation counting script and I performed the analysis for all 
datasets. 
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Introduction 
 
Many endogenous and exogenous stressors generate intracellular 
reactive oxygen species (ROS), which pose a threat to the chemical integrity of 
nucleic acids.  While much is known about the effects of DNA oxidation, little is 
known about the effects of RNA oxidation.  Accumulating evidence suggests 
RNA is more susceptible to ROS than DNA, with the prevailing ROS-induced 
adduct being 8-oxoguanosine (8oxoG) (Fiala et al. 1989; Shen et al. 2000; Hofer 
et al. 2005; 2006; Liu et al. 2012).  The in vivo basal levels of 8oxoG RNA range 
from 0.2 to 60 8oxoG per 105 G's, with levels significantly increasing upon 
exposure to oxidizing agents (Hofer et al. 2005; 2006; Liu et al. 2012; Simms et 
al. 2014).  The ability of 8oxoG to base pair with adenosine makes 8oxoG highly 
mutagenic and problematic (Yanagawa et al. 1992; Weimann et al. 2002; Hsu et 
al. 2004; Kim et al. 2004; 2006; Simms et al. 2014).   
Interestingly, high levels of oxidized RNA have been observed in many 
neurodegenerative disease states, including ALS, Alzheimer's, and Parkinson's 
(Nunomura et al. 1999; Zhang et al. 1999; Abe et al. 2002; Nunomura et al. 
2002; Abe et al. 2003; Shan et al. 2003; Chang et al. 2008; Nunomura et al. 
2012; 2009).  Although it is unknown whether oxidized RNA contributes to the 
pathology, some research has implicated a connection between oxidized RNA 
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and reduced translation efficiency.  For example, ribosomes purified from 
patients with Alzheimer's disease produced fewer protein products than 
ribosomes purified from aged-match controls (Ding et al. 2005).  Furthermore, in 
vitro translation of oxidized mRNA produces fewer full-length peptides while 
simultaneously increases the production of abortive peptides (Shan et al. 2007; 
Tanaka et al. 2007; Calabretta et al. 2015).  It has also been shown that the 
ribosome transit on 8oxoG is 100- to 1000-fold slower than on unmodified bases 
(Simms et al. 2014). 
There are currently a limited number of techniques available for the study 
of oxidized RNA.  HPLC-MS/MS and HPLC-ECD have been used to quantify 
8oxoG adducts in RNA and in DNA (Fiala et al. 1989; Park et al. 1992; Abe et al. 
2002; Weimann et al. 2002; Abe et al. 2003; Hofer et al. 2006).  Despite being 
highly sensitive, these instruments require a lot of sample material and molecular 
standards (Hofer et al. 2006).  Antibodies specific for 8oxoG also exist and have 
been used for immunohistochemistry and competitive ELISA (Park et al. 1992; 
Yin et al. 1995; Nunomura et al. 1999; 2002; Shan et al. 2007; Chang et al. 2008; 
Simms et al. 2014).  These low-resolution techniques all share a common 
problem in that they fail to provide information regarding sequence features.  For 
example, are specific motifs more prone to oxidation?  Are sequences less likely 
to be oxidized if they are embedded within secondary structures? 
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Reverse transcription can be used to identify adducts within a given 
sequence.  Reverse transcriptase (RT) inefficiently reads through base 
modifications (e.g. 8oxoG), giving rise to terminated cDNA products; analysis of 
cDNA lengths on a sequencing gel reveals the location of 8oxoG sites.  Thus, RT 
stops can detect regions prone to oxidation (Rhee et al. 1995; Gong et al. 2006).  
A major drawback of this approach, however, is the sequence of the transcript 
must be known and only one transcript can be analyzed at a time.   
The efficiency of RT read-through is more dynamic than a binary "stop" 
and "no-stop" action; rather, it is a parameter that can change depending on the 
type of RT and reaction conditions.  For instance, SHAPE experiments depend 
on SuperScript™ III termination at modified 2'-hydroxyls.  SHAPE reagents react 
with 2'-hydroxyls within flexible regions to form bulky adducts.  Thus, careful 
analysis of RT stops can be used to ascertain the secondary structure of various 
RNA species (Merino et al. 2005; Mortimer and Weeks 2007; McGinnis et al. 
2012).  After adjusting RT conditions to increase read-through at SHAPE 
adducts, deep-sequencing is a feasible option to determine the secondary 
structures of various RNAs.  Moreover, replacing MgCl2 with MnCl2 and using 
SuperScript™ II increases read-through events that manifest as quantifiable 
base substitutions and deletions in deep-sequencing data (Siegfried et al. 2014). 
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Here, we developed a high-throughput, high-resolution tool to detect and 
quantify oxidized RNA.  Our approach relies on the ability of RT to read through 
and introduce mutations across 8oxoG sites.  Analysis of oxidized in vitro 
synthesized RNA revealed increased G>T mutation rates compared to untreated 
RNA.  Furthermore, preliminary analysis of yeast treated with the oxidizing agent 
H2O2 showed increased G>T mutations.  Thus, we provide the foundation for a 
deep-sequencing approach to detect oxidized RNA.  
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Results 
 
One of the initial steps in creating RNA-sequencing libraries is reverse 
transcription of the RNA samples.  While it has been suggested that reverse 
transcriptase (RT) poorly reads through base adducts, this behavior appears to 
depend on the type of RT and the reaction conditions (Gong et al. 2006; 
Kladwang et al. 2012; Mohr et al. 2013; Siegfried et al. 2014).  We, therefore, 
sought to determine which RT enzymes read through 8oxoG sites by performing 
reverse transcription using synthesized 40mer RNA oligos that contained either a 
single 8oxoG or an unmodified guanosine (Figure 3.1, A).  A 21 nt DNA adaptor 
was ligated to the 3' end of the RNA oligos to serve as the priming site for a 32P-
end labeled oligo, and all reactions were performed according to manufacturer's 
instructions.  Of the enzymes tested, cDNA products from SuperScript™ II had 
the weakest signal corresponding to the 8oxoG site (Figure 3.1, B), whereas 
cDNA products from SuperScript™ III had the strongest.  These results suggest 
SuperScript™ II can read through 8oxoG sites. 
We next determined which conditions permitted the insertion of a mutation 
across the 8oxoG site.  SHAPE-Map experiments have successfully obtained 
mutations across SHAPE-modified bases by replacing 3 mM MgCl2 with 6 mM 
MnCl2 and allowing the reaction to run for three hours (Siegfried et al. 2014).  We 
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tested whether similar conditions would yield mutations at the 8oxoG site by 
generating deep-sequencing libraries from four different reverse transcription 
conditions (see Chapter III/Methods and Materials/Reverse Transcription for 
details).  Our data revealed a high incidence of G>T mutations in the 8oxoG RNA 
for all RT conditions (Figure 3.1, C).  The highest overall rate of G>T mutations 
resulted from using SuperScript™ II in buffer condition 1 (i.e. 3 mM MgCl2, one-
hour incubation), whereas substituting 3 mM MgCl2 with 6 mM MnCl2 decreased 
the G>T mutation rate at the 8oxoG site.  SuperScript™ II also had high G>G 
fidelity (> 95 x 10-2) in all reaction conditions containing the 40mer RNA.  Finally, 
SuperScript™ III (condition 4) exhibited the lowest G>T mutation rate and the 
highest G>G fidelity in reactions containing either the 40mer or 8oxoG RNAs. 
Our results suggest SuperScript™ II specifically produces G>T mutations 
at 8oxoG sites.  The G>T mutation rate at G29 (which corresponds to the 8oxoG 
site) was 0.30 x 10-2 in the 40mer RNA and 74.92 x 10-2 in the 8oxoG RNA.  
Second, the fidelity of unmodified guanosine was relatively comparable between 
the 40mer RNA and 8oxoG RNA.  The G>T mutation rate at G22 (unmodified in 
both the 40mer and 8oxoG RNAs) was 1.705 x 10-2 in the 40mer RNA and 0.885 
x 10-2 in the 8oxoG RNA.  Finally, the overall mutation rate of G>A or G>C was 
less than 3 x 10-2 for both RNAs.  This observed specificity is consistent with 
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previous reports suggesting 8oxoG preferentially base pairs with adenosine (Hsu 
et al. 2004; Kim et al. 2006; Simms et al. 2014). 
To estimate the rate at which SuperScript™ II stops at 8oxoG, we 
subtracted reads containing C28 from reads containing C30 and normalized to 
the total number of reads containing both C28 and C30.  This value 
corresponded to stops occurring immediately before or at the 8oxoG site (G29).  
Our calculation revealed a stopping rate of 2.61 x 10-2 for SuperScript™ II in 
buffer condition 1 (Figure 3.1, C).  While the stopping rate improved with the 6 
mM MnCl2 substitution and longer incubation time, the lower G>T mutation rate 
in these conditions led us to conclude that buffer condition 1 offered the best 
outcome for detecting 8oxoG sites in RNA.  We also note that SuperScript™ III 
had the highest – albeit marginal – stopping rate of 3.78 x 10-2.  Overall, our 
results suggest SuperScript™ II can read through 8oxoG modifications and 
introduce mutations.  
To further test our deep-sequencing approach, we included two additional 
in vitro transcribed RNA species in our libraries.  The in vitro transcribed RNAs 
(RP51A and P2-o41-o26) were oxidized using Fenton's reagent (Walling 1975).  
 
Fe2+ + H2O2 → Fe3+ + OH- + ˙OH 
Fe3+ + H2O2 → Fe2+ + ˙OOH + H+ 
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Ferrous iron (Fe2+) reacts with hydrogen peroxide (H2O2) to form ferric iron 
(Fe3+), hydroxide (OH-), and a hydroxyl radical (˙OH).  The reaction continues 
with the reduction of ferric iron to ferrous iron, producing a hydroperoxyl radical 
(˙OOH) and a proton; the resulting free radicals oxidize susceptible substrates, 
such as RNA (Walling 1975).  Oxidation of in vitro transcribed RNAs was verified 
by observing an increase in UV absorbance at 305 nm (Table 3.1) (Boateng 
2014).  
Our data showed that the oxidized in vitro transcribed RNA reads had a 
higher G>T mutation rate (unweighted average: 1.93 x 10-2; weighted average: 
1.62 x 10-2) compared to the untreated reads (unweighted average: 0.77 x 10-2; 
weighted average:  1.15 x 10-2) (Figure 3.1, D; see Chapter III/Methods and 
Materials/Deep-sequencing and data analysis for calculation details).  C>T 
was the second most prevalent mutation in the oxidized RNA reads, with an 
unweighted average rate of 1.3 x 10-2 (weighted average: 1.19 x 10-2).  This could 
be due to deamination of cytidine to uridine, which has been shown to occur on 
single-stranded DNA exposed to heat or alkaline solutions (Hurst and Kuksis 
1958; Ullman and McCarthy 1973; Lindahl and Nyberg 1974).  The C>T mutation 
was also the second highest mutation in the untreated sample, but only when 
error rates were averaged across sequences (0.76 x 10-2); weighted averages 
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revealed G>A to be the second highest mutation in the untreated sample (0.93 x 
10-2).  To estimate the overall sequencing error rate, we calculated the error rate 
in the untreated and 40mer RNA reads (unweighted average: 1.45 x 10-2; 
weighted average: 1.59 x 10-2).  This error rate was higher than previous reports 
(Minoche et al. 2011; Schmitt et al. 2012; Schirmer et al. 2016), and may be 
explained by the inclusion of low-quality reads in our analysis (quality score > 2).  
Overall, we conclude oxidized RNA results in a signature G>T mutation that can 
be detected via deep-sequencing. 
 We next tested whether a deep-sequencing approach can detect a higher 
G>T mutation rate in cells subjected to oxidative stress.  H2O2 treatment has 
been previously shown to induce oxidative stress in yeast (McKinlay et al. 2012).  
We established a survival curve of yeast treated with different concentrations of 
H2O2 and found that 1.5 mM allows for >50% survival (Figure 3.2, A).  H2O2 
treatment can introduce 8oxoG lesions in both RNA and DNA, with RNA 
procuring more adducts than DNA per cell (Hofer et al. 2005; 2006; Liu et al. 
2012).  To confirm our H2O2 treatment generated damaged nucleic acids, we 
measured the genomic mutation frequency by monitoring the rate of 
spontaneous resistance to canavanine.  Yeast incorporate this toxic arginine 
analog into proteins, resulting in aberrant proteins and cell death.  Canavanine, 
as well as arginine, is transported into the cell via an arginine membrane 
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permease (CAN1); however, mutations in the CAN1 gene can lead to a 
malfunctioning transporter, thus rendering yeast resistant to canavanine (CanR 
strains) (Ahmad and Bussey 1986).  Resistance to canavanine spontaneously 
arises in unadulterated yeast, but this rate increases upon treatment with 
damaging agents (Figure 3.2, B).  Treatment with H2O2 for ten minutes 
increased the frequency of CanR strains nearly six-fold, suggesting the DNA, and 
likely the RNA, was damaged. 
We prepared strand-specific libraries from H2O2-treated and untreated 
yeast as described in (Heyer et al. 2015) with some modifications.  Although 
oxidative stress generates 8oxoG lesions in vivo, certain procedures in library 
preparation can also oxidize nucleic acids (Chen et al. 2017).  For instance, the 
Broad Institute determined that acoustic shearing of DNA samples generates 
8oxoG lesions (Costello et al. 2013) that manifest as mutations in deep-
sequencing data.  This effect is due to the production of H2O2 from dissolved 
oxygen and heat (Bruskov et al. 2002); H2O2 subsequently reacts with metals, 
often present in trace amounts in standard buffers, to form free radicals (Costello 
et al. 2013).  Adding a metal chelator before heating the solution appears to 
prevent the formation of 8oxoG lesions (Bruskov et al. 2002; Hofer et al. 2006; 
Costello et al. 2013).  Gel-purification is another common procedure in library 
preparation that can oxidize nucleic acids.  Acrylamide polymerization is 
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facilitated by the strong oxidizing agent ammonium persulfate.  Gels used within 
a few hours after polymerization can introduce base lesions in nucleic acids, but 
this effect essentially disappears if gels are allowed to polymerize for more than 
twelve hours (Kladwang et al. 2012).  With these observations in mind, we 
modified our library preparation protocol to minimize oxidation of our samples.  
First, we included EDTA in our lysis buffer during total RNA extraction.  Second, 
we fragmented RNA by alkaline hydrolysis using sodium bicarbonate and EDTA.  
Finally, we allowed acrylamide gels to polymerize overnight prior to gel-
purification.  
Evidence from published work shows a basal level of approximately 6 
8oxoG per 104 G's in S. cerevisiae poly(A)-selected RNA (Simms et al. 2014) and 
< 1 8oxoG per 105 G's in E. coli total RNA (Liu et al. 2012).  However, these rates 
are lower than the sequencing error rate for the Illumina sequencing platform 
(Shendure and Ji 2008; Minoche et al. 2011; Schmitt et al. 2012; Schirmer et al. 
2016).  To enhance the sensitivity of our approach, our strategy includes 
sequencing overlapping paired-end (PE) reads, which has been shown to 
significantly decrease sequencing error (Chen-Harris et al. 2013; Preston et al. 
2016).  We identified sequencing errors as base calls present in one read but not 
in the reverse complement read.  125 bp PE sequencing of 100-150 nt inserts 
generated paired reads with substantial overlapping sequences that were 
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merged using a paired-end read merger (Zhang et al. 2014).  Subsequent quality 
filtering and end-trimming resulted in majority of bases with Phred-like quality 
scores > 35 (data not shown).  Thus, detected errors were likely from reverse 
transcription and PCR amplification.  Since default mapping parameters have a 
low threshold for base mismatches, we optimized parameters to permit more 
mutations without affecting mapping quality.  Our data revealed higher G>T 
mutation rates in H2O2-treated (2.17 G>T per 103 G's) yeast compared to 
untreated yeast (1.36 G>T per 103 G's) (Figure 3.2, C).  Furthermore, the G>T 
rate difference between the treated and untreated yeast was higher than the 
differences of other mutation rates, suggesting the high G>T mutation rate was 
likely due to 8oxoG sites.  Overall, we conclude that it is possible to use a deep-
sequencing approach to detect 8oxoG lesions in vivo. 
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Discussion 
 
We have developed a deep-sequencing approach to detect 8oxoG in 
RNA.  Prior to this work, methods to study oxidized RNA were limited to low-
resolution techniques.  HPLC-MS/MS and HPLC-EDC are highly sensitive at 
detecting and quantifying adducts; however, they afford no information on the 
RNA sequence and require substantial (several micrograms) of sample RNA 
(Fiala et al. 1989; Shen et al. 2000; Hofer et al. 2005; 2006; Liu et al. 2012).  
Antibodies specific to 8oxoG also exist, but have only been used for qualitative 
assessments, such as whether or not oxidized RNA is present in the tissue 
sample (Park et al. 1992; Yin et al. 1995; Nunomura et al. 2002; Shan et al. 
2007; Chang et al. 2008; Nunomura et al. 2012).  While a few studies were able 
to identify transcripts susceptible to oxidation (Shan et al. 2007; McKinlay et al. 
2012), information regarding sequence features is still lacking. 
Although previous studies monitored reverse transcriptase stops to 
determine the location of base modifications (Rhee et al. 1995; Gong et al. 
2006), we sought to establish conditions permitting read-through of oxidized 
bases.  Specifically, we found that SuperScript™ II reads through 8oxoG in 
standard reaction conditions (buffer condition 1) (Figure 3.1, B and C).  
Sequencing a 40mer RNA containing a single 8oxoG site demonstrated that the 
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most prevalent mutation from 8oxoG was G>T.  We also observed increased 
G>T mutations from in vitro synthesized RNAs that were oxidized via Fenton's 
reagent (Figure 3.1, D).  Finally, our preliminary data suggested that yeast 
treated with H2O2 exhibited higher G>T mutation rates compared to untreated 
yeast (Figure 3.2, C). 
 We took several steps to minimize error rates from sequencing and library 
preparation.  For instance, heating buffer solutions can generate H2O2 that, in 
turn, can react with trace amounts of metals to produce reactive oxygen species.  
To prevent oxidation of our samples, we added the metal chelator EDTA to the 
lysis and fragmentation buffers, which has been shown to reduce the occurrence 
of 8oxoG-induced G>T mutations (Bruskov et al. 2002; Costello et al. 2013).  We 
also sequenced and merged overlapping paired-reads to obtain consensus 
sequences.  This approach greatly reduces sequencing error because the 
probability of the sequencer inserting the same mismatch in the forward and 
reverse strand is extremely low (Chen-Harris et al. 2013; Preston et al. 2016).  
The cost of sequencing overlapping reads, however, is reduced coverage.  
Nevertheless, we were able to analyze our yeast datasets comprised of 
approximately 20 million merged reads per sample.  
 Although our preliminary analysis showed increased G>T mutations in 
yeast treated with H2O2, many aspects of this work need improvement.  For one, 
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more replicates are necessary to assess reproducibility; so far, this study only 
includes one in vivo experiment.  However, technical sequencing replicates of 
our yeast libraries revealed similar error rates between both datasets (data not 
shown).  Thus, we predict that any variability detected through additional 
biological replicates will stem from inherent biological variance or variance in 
library preparation.  Second, the presented analysis is limited to the overall 
transcriptome-wide mutation rate; therefore, information about sequence features 
requires further investigation.  For example, do G>T mutations reside within the 
ORF or UTRs?  Would we see more mutations in coding versus noncoding RNA 
(or vice versa)?  Do structured regions contain fewer mutations compared to 
unstructured regions?  Data from the present work could potentially answer these 
questions.  The Yeast Genome Browser contains over two hundred annotated 
tracks that can be downloaded and used to isolate reads mapping to a region of 
interest (i.e. UTRs).  Comparing G>T mutation rates among different regions may 
reveal sequence features that are more prone to oxidation.  Finally, our analysis 
does not exclude mutations arising from SNPs, which can be resolved by 
modifying our current software.  
 We generated strand-specific RNA-sequencing libraries using a protocol 
that our laboratory previously optimized (Heyer et al. 2015).  This protocol can 
easily be adapted to other types of specialized sequencing, such as ribosome 
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profiling (Ingolia et al. 2009) or 5'-phosphate sequencing (5PSeq) (Pelechano et 
al. 2015).  Since earlier work indicated that 8oxoG sites severely slow ribosome 
elongation kinetics (Simms et al. 2014), it would be interesting to see whether 
G>T mutations occur in-frame and/or within the A-site. 
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Methods and Materials 
 
All solution and enzyme concentrations are noted as their final concentration in 
the reactions. 
 
RNA oligos 
Two RNA oligos, with (40mer RNA) or without 8oxoG (8oxoG RNA), was 
synthesized by Boston Open Labs (BOL; Cambridge MA).  The sequence of both 
RNA oligos was 5' HO-
GGAAUCUCUCUCUCUCUCUAUGUUCUUCGCUUUCUUCUAA-OH 3', where 
"G" was either guanosine or 8oxoG. 
 
Hot Reverse Transcription 
A miRCat-33 3' preadenylated adaptor (5' - 
AppTGGAATTCTCGGGTGCCAAGGddC - 3') was ligated to the 40mer and 
8oxoG RNA as described below in "Ligation to preadenylated 3' adaptor".  The 3' 
adaptor served as a priming site for the reverse transcription reaction.  T4 PNK 
(NEB M0201S) was used for 32P end-labeling of an RT primer that is reverse 
complementary to the adaptor sequence.  A mixture of 43 nM of ligated 40mer 
and 8oxoG RNA, 130 nM of labeled RT primer, and 0.5 mM dNTPs was heated 
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at 65°C for 5 minutes, then immediately chilled on ice.  Next, 50 mM Tris-HCl pH 
= 8.3, 75 mM KCl, 5 mM DTT, and 5.3 units/uL of either SuperScript™ II 
(ThermoFisher 18064014), SuperScript™ III (ThermoFisher 18080093), or 
PrimeScript™ (CloneTech 2680A) was added to the mixture and incubated at 
42°C (SuperScript™ II and PrimeScript™) or 55°C (SuperScript™ III) for 45 
minutes.  Enzymes were inactivated by heating the reaction to 70°C for 15 
minutes.  Samples were loaded on a 20% denaturing polyacrylamide gel.  
Analysis was performed using ImageQuant.  Full-length cDNA product and the 
band corresponding to the 8oxoG site were normalized to free primers. 
 
In vitro transcription 
A PCR product containing a T7 promoter and part of the yeast RP51A DNA 
sequence was in vitro transcribed using the RiboMax Large Scale RNA 
Production – T7 kit (Promega P1300).  The final RP51A RNA product (381 nt) 
was subsequently gel-purified from a 5% denaturing polyacrylamide gel.  A PCR 
product containing a T7 promoter and the P2-o41-o26 DNA sequence was also 
in vitro transcribed using the same conditions.  The final P2-o41-o26 RNA 
product (120 nt) was gel-purified from a 10% denaturing polyacrylamide gel. 
 
Oxidation of in vitro transcribed RNA 
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A solution of 60 uM Fe2(SO4)3, 1 mM H2O2, and 73 ng/uL of RP51A or P2-o41-
o26 RNA was incubated at room temperature for 1 minute 30 seconds.  6 mM 
EDTA was added to stop the reaction.  Successful oxidation of RNAs was 
verified by observing an increased in UV absorbance at 305 nm.  Integrity of the 
oxidized RNA was assessed by denaturing gel electrophoresis. 
 
Percent survival of H2O2-treated yeast 
The percent survival of yeast treated with various H2O2 concentrations was 
determined.  First, cultures of BY4741 wild-type yeast were grown in YPD 
overnight at 30°C to mid-log phase.  Cultures were then diluted with fresh YPD to 
7.5 x 106 cells/mL and treated with various concentrations of H2O2 for 10 minutes 
at 30°C.  Next, 25 units/mL of Catalase from bovine liver (Sigma Aldrich C1345-
10G, resuspended in 50 mM KH2PO4 pH = 7.0 and filtered) was used to removed 
H2O2 from the cultures.  100 uL of a 1:2000 dilution of treated and untreated 
yeast was plated onto pre-warmed YPD plates.  Plates were incubated for 3 days 
at 30°C.  The number of colonies were counted and results were used to 
determine colony forming units per milliliter (CFU/mL).  CFU/mL of H2O2-treated 
yeast was normalized to the CFU/mL of untreated yeast to obtain the percent 
survival.  
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Genomic mutation frequency of H2O2-treated yeast 
The genomic mutation frequency of yeast treated with 1.5 mM H2O2 was 
determined by calculating the rate of spontaneous resistance to Canavanine.  An 
aliquot of H2O2-treated and untreated yeast (see above) was plated onto YPD or 
Arg- plates containing 60 ug/mL Canavanine.  Plates were incubated for 3 days 
at 30°C.  The number of colonies was counted and results were used to 
determine the number of Canavanine resistant colonies (CanR) per 106 cells. 
 
Yeast treatment with H2O2 for deep-sequencing libraries  
A culture of BY4741 wild-type yeast was grown in YPD overnight at 30°C to mid-
log phase.  Cells were diluted to 7.5 x 106 cells/mL in fresh YPD and split into two 
cultures.  1.5 mM H2O2 was added to one culture, and both cultures were 
incubated for 10 minutes at 30°C.  13 units/mL of Catalase was added to both 
cultures and an aliquot of cells was immediately removed and frozen in liquid 
nitrogen.  Another aliquot of cells was used to determine the percent survival and 
genomic mutation frequency (see above). 
 
Isolation of yeast RNA for deep-sequencing libraries 
Total RNA from untreated and H2O2-treated yeast (see above) was isolated as 
previously described (Amberg et al. 2006).  Ribosomal RNA and RNAs < 200 nt 
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were depleted from total RNA using the RiboZero Gold Magnetic Kit (Yeast) 
(Epicenter MRZ116C) and a size selection column (Zymo Research RNA Clean 
and Concentrator – 5 R1016) respectively.  The resulting pool of rRNA- and <200 
nt-depleted yeast RNA was analyzed on the Agilent Bioanalyzer 2100. 
 
Fragmentation 
Synthesized RNA samples:  ~1 uM of untreated and oxidized RP51A RNA was 
fragmented in 1X Fragmentation Buffer 1 (50 mM Tris-HCl pH = 8.3, 15 mM 
MgCl2) at 90°C to obtain fragment sizes of 30-150 nt.  Samples were immediately 
put on ice to stop the reaction, then precipitated by EtOH.  The P2-o41-o26, 
40mer, and 8oxoG RNA samples were not fragmented. 
 
Yeast RNA samples:  rRNA- and < 200 nt-depleted yeast RNA was fragmented 
by alkaline hydrolysis.  A solution containing ~2 ng/uL of RNA, 55.6 mM NaHCO3 
pH = 9.2, and 1 mM EDTA was heated to 95°C for 5 minutes.  To stop the 
reaction, 280 mM NaOAc pH = 5.2 and 0.22 mg/mL Glycogen was added and 
samples were immediately chilled on ice.  Fragmented RNAs were then 
precipitated by EtOH.  This condition yielded a fragment size range of 100 – 150 
nt as assessed by the Agilent Bioanalyzer 2100. 
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Dephosphorylation of 3' ends 
All RNA samples were dephosphorylated using T4 PNK and standard T4 PNK 
buffer without ATP. 
 
Preadenylation of 3' adaptor 
A miRCat-33 3' adaptor with a 4N randomer (5' P-
NNNNTGGAATTCTCGGGTGCCAAGG-OH 3') was synthesized by IDT and 
subsequently adenylated using the 5' DNA Adenylation Kit (NEB E2610L).  
Adenylated products were gel-purified. 
 
Ligation to preadenylated 3' adaptor 
0.13 uM of fragmented and dephosphorylated RNA was ligated to 0.47 uM 3' 
preadenylated adaptor for 6 hours at 30°C using 6 units/uL T4 RNA Ligase 2, 
truncated K227Q (NEB M0351L) in standard reaction buffer (50 mM Tris-HCl pH 
= 7.5, 10 mM MgCl2, 2 mM DTT, and 25% PEG-8000).  The reaction was heated 
to 65°C for 20 minutes to inactivate the enzyme.  Samples were then precipitated 
by EtOH. 
 
Reverse Transcription 
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Synthesized RNA samples:  Untreated in vitro transcribed RNA and 40mer RNA 
samples were pooled together before the reverse transcription reaction.  
Similarly, oxidized in vitro transcribed RNA and 8oxoG RNA samples were also 
pooled before the reverse transcription reaction.  A mixture of 0.1 uM of ligated 
RNA samples, 0.5 uM barcoded RT primer, and 0.5 mM dNTPs was heated to 
65°C for 5 minutes, then immediately chilled on ice.  Condition 1) 1X SII buffer 
(50 mM Tris-HCl pH = 8.3, 75 mM KCl, 10 mM DTT), 3 mM MgCl2, and 10 
units/uL of SuperScript™ II was added to the mixture and the reaction was 
incubated at 42°C for 1 hour.  Condition 2) 1X SII buffer, 6 mM MnCl2, and 10 
units/uL of SuperScript™ II was added to the mixture and incubated at 42°C for 1 
hour.  Condition 3) The same as Condition 2 except the reaction was incubated 
for 3 hours.  Condition 4) 1X SIII buffer (50 mM Tris-HCl pH = 8.3, 75 mM KCl, 5 
mM DTT), 3 mM MgCl2, and 10 units/uL of SuperScript™ III were added to the 
mixture and the reaction was incubated at 55°C for 1 hour.  All reactions were 
stopped by incubating the reactions at 70°C for 15 minutes, then adding 
denaturing loading buffer immediately afterward.  cDNA products (size range 105 
– 220 nt) were purified from a 10% denaturing polyacrylamide gel and 
precipitated by EtOH. 
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Yeast RNA samples:  A mixture of ~0.1 uM of ligated RNA, 0.5 uM barcoded RT 
primer, and 0.5 mM dNTPs was heated to 65°C for 5 minutes, then immediately 
chilled on ice.  1X SII buffer, 3 mM MgCl2, and 10 units/uL of SuperScript™ II 
were added to the mixture and the reaction was incubated at 42°C for 1 hour.  All 
reactions were stopped by incubating the samples at 70°C for 15 minutes, then 
adding denaturing loading buffer immediately afterward.  cDNA products (size 
range 195 – 245 nt) were purified from a 10% denaturing polyacrylamide gel and 
precipitated by EtOH. 
 
Circularization 
Gel-purified cDNA products were incubated with 1X CircLigaseI Reaction Buffer 
(50 mM MOPS pH = 7.5, 10 mM KCl, 5 mM MgCl2, 1 mM DTT), 2.5 mM MnCl2, 
50 uM ATP, 1 M Betaine, 50 nM single-stranded DNA, and 5 units/uL Cerclages 
ssDNA Ligase (Epicentre Biotechnologies CL4115K) at 60°C for 4 hours.  The 
reaction was stopped by incubating the samples at 80°C for 10 minutes. 
 
PCR Amplification of circularized cDNA products 
All PCR reactions were performed using the KAPA HiFi Library Amplification Kit 
(KAPA Biosystems KK2611), gel-purified PE1.0 and PE2.0 Illumina primers, and 
circularized cDNA products (comprising up to one-fifth of the PCR reaction 
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volume).  Small-scale PCR reactions were performed to determine the 
appropriate PCR cycle that yielded a product of expected size without depleting 
the primer pool.  After completing a large-scale PCR amplification, PCR products 
were prepared for and purified from the PippinHT instrument (synthesized RNA 
samples: size range 160-271 bp; yeast RNA samples: size range 251-301 bp). 
 
Deep-sequencing and data analysis 
Synthesized RNA Libraries:  Samples were prepared and pooled for single-end 
100 bp sequencing on the Illumina HiSeq2000 sequencing platform (UMassMed 
Sequencing Core).  Barcoded libraries were sequenced with 90% PhiX.  The 
adaptor sequence was trimmed and reads were separated by barcode.  Reads 
were first mapped to the PhiX174 reference genome using Bowtie 2 (default 
parameters).  All reads not mapped to the PhiX174 genome were mapped to a 
reference genome comprised of the RP51A, P2-o41-o26, and the 40mer 
sequences using Bowtie 2 (default parameters).  Reads with quality scores > 2 
were isolated and reads mapping to the reverse strand were removed.  Reads 
were visualized on IGV and mutations were counted using an in-house 
developed script.  Unweighted averages were obtained by calculating the 
average mutation rate between RP51A and P2-o41-o26 at each base and across 
bases.  Weighted averages were calculated the same way except the 
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contribution of each RNA species was weighted according to its total number of 
read bases. 
 
Yeast RNA Libraries:  Samples were prepared and pooled for paired-end 125 bp 
sequencing on the Illumina HiSeq2500 sequencing platform (New York Genome 
Center).  Barcoded libraries were sequenced with 5% PhiX.  Paired-end reads 
were first separated by barcode, then merged using PEAR v0.9.4.  The 3' 
adaptor sequence and 5' CC was trimmed using CutAdapt v1.7.1 and the 
resulting reads with < 5 bases were removed using CutAdapt v1.9.  The 4N 
randomer was appended to the header using GCAT UMI-tools.  Read ends with 
a Phred score < 40 were trimmed using Trimmomatic v0.32.  Next, reads were 
mapped to the yeast reference genome (sacCer3) using TopHat v2.0.14 with the 
following parameters:  -N 5 --read-edit-dist 5 --read-realign-edit-dist 0 –i 40 –I 
2000 –p 4 --no-coverage-search --library-type fr-secondstrand --segment-
mismatches 3 --max-segment-intron 2000 --b2-D 20 --b2-R 4 --b2-N 1 --b2-L 10 -
-b2-I S,1,1.15.  Mapped reads were then analyzed using a script that determines 
the number and type of base mutations. 
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Figure 3.1: Reverse transcription of oxidized RNA 
(A) Diagram of 40mer and 8oxoG RNA ligated to 21 nt DNA adaptor (italicized).  
Site of 8oxoG (G29) indicated in red bold.  (B) Hot reverse transcription of 40mer 
and 8oxoG reporters.  The adaptor sequence served as the priming site for the 3' 
end-labeled primer.  cDNA products analyzed on a 20% denaturing 
polyacrylamide gel.  Signal intensity corresponding to full-length product and 
8oxoG stop were normalized to free primer (n=1).  (C) Deep-sequencing of 
40mer and 8oxoG oligos.  Showing results of mutational analysis at 8oxoG site.  
(D)  Mutational analysis of deep-sequenced in vitro synthesized RNA.   Top: 
Frequency of called base for reference base G (unweighted averages).  Bottom: 
Difference in mutation rate between H2O2-treated and untreated yeast for all 
possible base substitutions.  A positive value indicates that H2O2-treated had a 
higher mutation rate than untreated yeast. 
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Figure 3.2: cDNA variant sequencing of yeast treated with H2O2 
(A) Percent survival of yeast treated with various concentrations of H2O2.  Error 
bars represent standard error of the mean (n=3).  (B)  Percent survival and 
frequency of CanR strains upon treatment with 1.5 mM H2O2.  Average results of 
three biological replicates and standard error of the mean (SEM).  (C)  Deep-
sequencing of RNA from H2O2-treated and untreated yeast.  Results of 
mutational analysis with the top four occurring mutations shown. 
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 Abs 260 nm Abs 305 nm 
40mer RNA 2.470 0.088 
8oxoG RNA 2.430 0.127 
Untreated RP51A 4.286 0.069 
Oxidized RP51A 3.817 0.145 
Untreated P2-o41-o26 2.323 0.054 
Oxidized P2-o41-o26 2.181 0.116 
 
Table 3.1: Absorbance of untreated and oxidized RNA 
UV absorbance of 40mer RNA oligos and in vitro synthesized RNAs. 
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CHAPTER IV.  DISCUSSION 
 
Part 1.  ASC1 and RPS3:  New actors in 18S nonfunctional rRNA decay 
 
18S rRNA containing inactivating mutations within the decoding center is 
subject to quality control known as nonfunctional rRNA decay (18S NRD).  
Previous work from our lab demonstrated a convergence between 18S NRD and 
other translation-dependent pathways (LaRiviere et al. 2006; Cole et al. 2009).  
Although deletion of NGD factors DOM34, HBS1, or both decreases 18S NRD 
kinetics, the observation that cycloheximide treatment completely abrogates 18S 
NRD suggested other factors must contribute (Cole et al. 2009).  Moreover, our 
unpublished data suggested that RQC/PDTA factor ASC1 contributes to 18S 
NRD (Merrikh 2012).   
The goal of Chapter II was to identify additional 18S NRD factors to further 
our understanding of rRNA quality control.  We demonstrated that deletion of 
ASC1 partially stabilizes 18S:A1492C, whereas deletion of either DOM34 or 
HBS1 in the asc1∆ strain completely stabilizes 18S:A1492C (Figure 2.2, A and 
B; Figure 2.4, A).  These data indicate that 18S NRD can be divided into 
genetically separable pathways, with ASC1 functioning in parallel with 
DOM34:HBS1.  We also identified RPS3 as a central component of 18S NRD.  
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Deletion of a six amino-acid region within the Rps3p C-terminal tail decreased 
18S NRD kinetics by >11-fold (Figure 2.6, B), the largest effect from any single-
mutant tested.  Finally, we found deletion of SKI2 partially stabilizes 
18S:A1492C, but is synthetic with neither DOM34 nor ASC1 (Figure 2.4, A).  
Overall, we conclude that multiple, redundant pathways exist for the target and 
decay of nonfunctional 18S rRNA. 
 This work along with others suggests a central role of RPS3 in translation-
dependent quality control.  In particular, the post-translational modification of the 
Rps3p C-terminal tail appears to mark stalled ribosomes for quality control.  
Recent studies determined that S. cerevisiae Hel2p ubiquitinates Rps3p (uS3) 
K212 and Rps20p (uS10) K6/K8 of stalled ribosomes (Matsuo et al. 2017; Simms 
et al. 2017).  In mammalian cells, ZNF598 (yeast HEL2) and RACK1 (yeast 
ASC1) both participate in the ubiquitination of stalled ribosomes, with ZNF598 
primarily participating in RPS10 (eS10) and RPS20 (uS10) ubiquitination, and 
RACK1 primarily participating in RPS3 (uS3) and RPS2 (uS5) ubiquitination 
(Juszkiewicz and Hegde 2017; Sundaramoorthy et al. 2017).  Notably, small-
molecule activators of the unfolded protein response pathway or inhibitors of 
translation elongation both lead to the ubiquitination of RPS3 at the site 
equivalent to yeast K212 (Higgins et al. 2015; Juszkiewicz and Hegde 2017; 
Sundaramoorthy et al. 2017).  In our study, deleting amino acids 212-217 of 
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RPS3 nearly abrogated 18S NRD (Figure 2.6, B), whereas single deletion of 
ASC1 only partially stabilized 18S:A1492C (Figure 2.2, B).  The different kinetic 
contributions of ASC1 and RPS3 would be consistent with the scenario in which 
Asc1p and another factor (possibly Hel2p) converge to ubiquitinate Rps3p on 
stalled ribosomes and initiate quality control. 
 Since ubiquitination of Rps3p K212 appears to mark stalled ribosomes 
(Matsuo et al. 2017; Simms et al. 2017), it would be worth investigating whether 
the same ubiquitination pattern occurs during 18S NRD.  A mutational analysis of 
the 212-217 region would ascertain whether one, some, or all of the amino acids 
are required for 18S NRD, and testing whether 18S NRD disappears in hel2∆ 
and rps3 K212A yeast strains may provide evidence of Hel2p-dependent 
ubiquitination.  Deletion of amino acids 212-217 in Rps3p may prevent K212 
ubiquitination, but it is equally possible that the remaining five amino acids might 
have functional relevance, such as serving as a binding site for Hel2p or other 
factors.  Another experiment would be to purify 18S:A1492C-containing 
ribosomes and perform mass spectrometry to see if Rps3p K212 and/or other 
ribosomal proteins are ubiquitinated during 18S NRD.  
 Interestingly, a small body of literature suggests RPS3 moonlights as a 
DNA damage repair factor.  Purified Drosophila RPS3 exhibits cleavage activity 
on double-stranded DNA containing 8oxoG or apurinic/apyrimidinic (AP) lesions.  
CHAPTER IV   
 
122 
The authors proposed that Drosophila RPS3 removes 8oxoG using its N-
glycosylase activity, then proceeds to cleave the phosphodiester bond via a type 
1 beta-elimination reaction (Wilson et al. 1993; 1994; Yacoub et al. 1996; 
Deutsch et al. 1997; Hegde et al. 2001).  This lyase activity appears to be 
conserved since another group independently discovered the AP lyase activity of 
human RPS3 after performing a series of biochemical fractionation experiments 
(Kim et al. 1995; Hegde et al. 2004).  Although recombinant human RPS3 does 
not contain N-glycosylase activity, it exhibits strong binding affinity to 8oxoG 
substrates (Hegde et al. 2006).  While evidence of lyase activity came from 
purified RPS3, it would be interesting to know whether RPS3 harbors this activity 
in the context of the ribosome.  Indeed, one group investigated whether human 
RPS3 exhibits AP lyase activity while bound to the 40S subunit; however, the 
authors observed no cleavage events.  Rather, it appears that 40S-bound RPS3 
is able to recognize AP sites since RPS3 crosslinked with AP DNA substrates in 
the presence of sodium cyanoborohydride20 (Grosheva et al. 2017).  The activity 
differences between free and 40S-bound RPS3 might imply that the joining of the 
60S subunit to form 80S ribosomes could modulate the activity of RPS3.  For 
																																																						
	
20 The lyase mechanism includes the formation of a Schiff base intermediate 
between the enzyme and the ribose C1' moiety.  Reducing agents, such as 
sodium cyanoborohydride, can covalently trap lyases in this intermediate step 
(Grosheva et al. 2017). 
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example, during the translation of an abasic mRNA, RPS3 might recognize and 
bind to the abasic site to promote ribosome stalling.  If so, RPS3 may connect 
translation-dependent quality control to RNA damage by recognizing aberrant 
modifications on mRNA. 
18S NRD shares many qualities with other translation-dependent 
surveillance pathways.  For instance, factors that participate in NGD (DOM34 
and HBS1), NSD (SKI7 and SKI2), and PDTA/RQC (ASC1) also participate in 
18S NRD (Chapter II) (Cole et al. 2009).  Despite being discovered 
independently of each other, emerging evidence suggests these pathways 
merely describe different outcomes of the same initiating event – a stalled or 
severely slowed ribosome.  How do stalling events trigger quality control and how 
are they different from normal stalling events (e.g. targeting for endoplasmic 
reticulum)?  To help answer this question, one group examined kinetic models of 
three stalling scenarios:  1) an individual ribosome encounters a stall site and 
triggers quality control; 2) the stalled ribosome causes a traffic jam so severe that 
it prevents ribosomes from initiating; or 3) trailing ribosomes collide with each 
other, and the collision event triggers quality control (Ferrin and Subramaniam 
2017).  The authors showed that the ribosome collision model closely matched 
experimentally determined protein-synthesis rates from a library of stalling 
reporters (Ferrin and Subramaniam 2017).  Evidence from yeast further 
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corroborates this finding (Simms et al. 2017).  Sequencing of stalling reporters 
revealed multiple cleavage sites occurring approximately every 30 nt (the size of 
a ribosome footprint) upstream of the stall site and in one frame.  In addition, 
cleavage efficiency increased as the distance between the start codon and stall 
site increased (Simms et al. 2017).  These data indicate that several ribosomes 
engage on the same aberrant mRNA and cleavage takes place between closely 
stacked ribosomes.  To model collision events in vivo, the authors created a 
yeast strain that housed a mixed population of cycloheximide-resistant and 
cycloheximide-sensitive ribosomes.  In the presence of cycloheximide, resistant 
ribosomes continue to elongate and eventually collide with sensitive ribosomes.  
This system allowed the authors to demonstrate that collision events lead to the 
Hel2p-dependent ubiquitination of Rps3p at amino acid K212 (Simms et al. 
2017).  Thus, ribosome collision likely initiates translation-dependent quality 
control.   
How might 18S NRD fit into this model?  Does 18S:A1492C lead to 
ribosome collision?  While ribosome density positively correlates with NGD 
efficiency, the nature of the stall site appears to modulate this interaction; that is, 
a stronger stall site diminishes the effect of ribosome density on NGD efficiency 
by increasing ribosome dwell time (Simms et al. 2017).  Thus, strong stallers 
bypass the need for ribosome collision to initiate NGD.  18S:A1492C likely fits 
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into the category of strong stallers.  The highly conserved A1492 in 16S rRNA 
(A1755 in S. cerevisiae 18S rRNA) assists in codon:anticodon pairing at the 
second position.  A1492 mutations impair tRNA-binding at the A-site in vitro and 
are dominant lethal in E. coli (Powers and Noller 1990; 1993; Yoshizawa et al. 
1999b; LaRiviere et al. 2006).  Thus, the strong stalling effect of 18S:A1492C 
could bypass the need for collision-based initiation of 18S NRD.  Nevertheless, 
the slow decay rate of 18S:A1492C (half-life: 41 to 96 minutes) (Chapter II) 
(LaRiviere et al. 2006; Cole et al. 2009) compared to other stalling mRNA 
reporters (half-life: 2 to 9 minutes) (Frischmeyer et al. 2002; Doma and Parker 
2006; Sweet et al. 2012; Tsuboi et al. 2012) suggests targeting of 18S:A1492C 
for NRD is relatively inefficient. 
The numerous studies examining the fate of nascent peptides associated 
with stalled ribosomes has given us some idea on what happens to the 60S 
subunit.  For example, the 60S subunit likely remains intact since stalled 80S 
complexes are dissociated before the final steps of the RQC pathway (CAT-
tailing, Ltn1p ubiquitination, and hydrolysis of the peptidyl-tRNA) isolate and 
remove the aberrant nascent peptide (Brandman and Hegde 2016).  This would 
be consistent with the observation that the decay of 25S rRNA harboring 
mutations in the peptidyl-transfer center (25S NRD) happens via a mechanism 
that is distinct from 18S NRD and other translation-dependent pathways 
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(LaRiviere et al. 2006; Cole et al. 2009; Fujii et al. 2009; 2012) (see Chapter I).21  
Thus, a probable outcome for the 60S subunit is that it is recycled into new 80S 
complexes. 
Conversely, the fate of the 40S subunit remains elusive.  What happens to 
the 40S subunit?  In order for exonucleases to gain access to 18S:A1492C 
during 18S NRD, one could predict that some or all of the 40S proteins 
disassemble either before or simultaneous to decay.  If so, are the 40S proteins 
degraded or are they reassembled with new 18S rRNA?  Can cells distinguish 
between nonfunctional 18S rRNA from aberrant mRNA?  Is the associated 
mRNA cleaved during 18S NRD?  Given the overlapping features between 18S 
NRD and NGD/NSD/PDTA/RQC, it is possible that cells degrade both the 18S 
rRNA and mRNA.  Alternatively, subtle differences (e.g. in the ubiquitination 
pattern) may communicate whether the source of ribosome stalling comes from 
the nonfunctional 18S rRNA or aberrant mRNA.  A key long-term question for the 
field is whether 18S NRD is functionally different from NGD/NSD/PDTA/RQC 
pathways.  Providing answers to these questions will add to our growing 
understanding of 18S NRD and other translation-dependent quality control 
pathways. 
																																																						
	
21 We have preliminary data suggesting 25S NRD still happens in the  
rps31-211 mutant (data not shown). 
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Part 2.  A deep-sequencing approach to detect oxidized RNA 
 
 The studies in Chapter III serve as the foundation for the development of a 
deep-sequencing approach to detect oxidized RNA.  Prior to this work, low-
resolution methods were routinely used to detect 8oxoG and other types of 
damaging adducts.  HPLC-MS/MS and HPLC-ECD can detect and quantify 
modifications, and have been used to demonstrate that RNA is more susceptible 
to various damaging agents than DNA (Fiala et al. 1989; Abe et al. 2002; 2003; 
Hofer et al. 2005; 2006).  Data establishing the presence of oxidized RNA in 
Alzheimer's, Parkinson's, and ALS came from immunohistochemistry 
experiments using antibodies specific to 8oxoG (Park et al. 1992; Yin et al. 1995; 
Nunomura et al. 1999; 2002; Shan et al. 2007; Chang et al. 2008; Nunomura et 
al. 2012).  These techniques, however, do not provide information regarding 
transcript or sequence features.  So far, measuring reverse transcriptase (RT) 
stops at modified sites is the only tool that can provide sequence and nucleotide 
information, but analysis is limited to one transcript at a time (Iordanov et al. 
1998; Gong et al. 2006; Hostetter et al. 2012; Kladwang et al. 2012).   
Our work aimed at developing a deep-sequencing method to detect 
damaged RNA at nucleotide resolution.  This approach relies on the ability of RT 
to read through and introduce mutations across damaged sites.  Being the most 
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prevalent adduct formed from reactive oxygen species (ROS) – and since 
numerous stressors generate intracellular ROS (Fiala et al. 1989; Nunoshiba and 
Demple 1993; Bruskov et al. 2002; Cadet et al. 2005; Rada and Leto 2008; 
Carozzi et al. 2010) – made 8oxoG a suitable model lesion for our studies.  
Analysis of cDNA products from an oligo containing a single 8oxoG 
demonstrated that SuperScript™ II can read through and introduce G>T 
mutations at 8oxoG sites (Figure 3.1, B and C); cDNA products from oxidized in 
vitro synthesized RNA confirmed these findings (Figure 3.1, D).  Although 
previous research determined that substituting MgCl2 with MnCl2 improved read-
through at bulky adducts (e.g. SHAPE) (Siegfried et al. 2014), we found that 
standard reaction conditions (condition 1; 3 mM MgCl2, 1-hour incubation) 
yielded the most G>T mutations (Figure 3.1, C).  Finally, our preliminary analysis 
showed increased G>T mutations in yeast treated with H2O2 (Figure 3.2, C)22.  
One of the challenges of detecting true mutations from false positives 
derives from the inherent error rate of sequencing platforms.  For example, the 
Illumina HiSeq sequencing platform can exhibit substitution error rates as high as 
1.6 x 10-3, even after stringent quality-filtering of aligned reads (Minoche et al. 
2011; Schirmer et al. 2016).  This error rate is higher than reported 8oxoG rates 
																																																						
	
22 Based on one biological replicate 
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occurring in vivo (0.2 to 60 8oxoG per 105 G's) (Hofer et al. 2005; 2006; Liu et al. 
2012; Simms et al. 2014).  To overcome the high error rate of deep-sequencing, 
we sequenced libraries containing short inserts to generate overlapping paired-
end reads.  This method has been previously established to significantly reduce 
sequencing error, with the number of paired reads containing mismatched base-
calls declining from ~6.7 x 10-3 (unfiltered read pairs) to ~2.5 x 10-7 (filtered by 
quality score >35) (Chen-Harris et al. 2013; Preston et al. 2016), well below the 
reported 8oxoG rates (Hofer et al. 2005; 2006; Liu et al. 2012; Simms et al. 
2014).  FastQ assessment of merged reads from our yeast experiments reported 
Phred-like quality scores of >38 per base for the first 95 bases (data not shown).  
Our preliminary analysis showed G>T rates of 1.36 per 103 G's in untreated yeast 
and 2.17 per 103 G's in H2O2-treated yeast (Figure 3.2, C), suggesting that the 
errors likely originated from reverse transcription and PCR.  Indeed, we observed 
similar mutation rates after resequencing the same yeast library (data not 
shown).23   
We prepared strand-specific RNA-Seq libraries from in vitro synthesized 
RNA and yeast total RNA using our in-house developed protocol (Heyer et al. 
2015).  For our yeast libraries, we depleted rRNA and tRNA from total RNA to 
																																																						
	
23 To really evaluate the merit of sequencing overlapping paired-end reads, we 
could compare mutation rates from merged reads to unmerged reads.    
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increase the sensitivity of our mutational analysis given the recent evidence of 
poly(A)-selected RNA being more susceptible to oxidation than total RNA 
(Simms et al. 2014).  However, certain procedures in library preparation damage 
nucleic acids, which can manifest as base substitutions in deep-sequencing data.  
For instance, excessive heating (e.g. during nucleic acid fragmentation) 
generates ROS that, in turn, react with guanosine to form 8oxoG; in this regard, 
G>T mutations result from polymerases incorporating adenosine across 8oxoG 
(Costello et al. 2013; Chen et al. 2017).  Therefore, we adjusted our library 
preparation protocol to minimize exposure to damaging agents.  We added the 
metal chelator EDTA during our lysis and fragmentation steps, we allowed 
acrylamide gels to polymerize for >24 hours, and we used low-energy lamps to 
visualize RNA during gel-purification.  Although we did not empirically determine 
whether each change affected the signal-to-noise ratio, earlier research has 
provided evidence that such changes help reduce the formation of 8oxoG and 
uridine dimers (Bruskov et al. 2002; Hofer et al. 2006; Kladwang et al. 2012; 
Costello et al. 2013). 
Our analysis employed a simple mutation-counting software to quantify 
the global mutation rate for each base.  Although this software was sufficient for 
our oligo and in vitro synthesized RNA libraries, our yeast libraries require more 
sophisticated analyses.  For example, we did not distinguish random base 
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substitutions from bona fide SNPs in our yeast dataset (Chen-Harris et al. 2013; 
Preston et al. 2016).  A possible solution would be to isolate reads that contain 
the same mutation in the same position over a certain threshold.  With this 
information, we could modify the reference genome, remap the dataset, then 
repeat our mutation analysis.  Doing so may increase the single-to-noise ratio 
without having to discard reads.  Additionally, a subset of mutations in the RNA-
Seq data may have derived from oxidized DNA.  RNA transcribed from DNA 
containing an oxidized-induced mutation would manifest as mutations in the 
dataset.  A possible approach to overcome this issue is to overexpress the yeast 
DNA repair enzyme OGG1.  Ogg1p is a combined DNA glycosylase and lyase 
that specifically excises 8oxoG residues in nuclear or mitochondrial DNA (van 
der Kemp et al. 1996; Singh et al. 2001).  Ogg1p overexpression might protect 
the yeast genome from accumulating mutations due to 8oxoG DNA; if so, this 
approach would further increase the likelihood that the G>T mutations in the 
RNA-Seq dataset are due to oxidized RNA rather than DNA. 
Preliminary analysis of the yeast libraries came from one biological 
replicate.  Our results look promising, however, since the simple mutation-
counting software detected increased G>T incidences in H2O2-treated yeast 
compared to untreated yeast (Figure 3.2, C).  We are currently making libraries 
from additional yeast experiments to assess reproducibility.  Our replicate 
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libraries also contain varying amounts of the 40mer and 8oxoG oligos in order to 
measure the sensitivity of our assay.  Analysis of datasets produced from these 
libraries will determine the minimum coverage necessary to reliably detect 
8oxoG-induced mutations.  To further increase the sensitivity of our assay, we 
can prepare libraries from pull-down experiments using antibodies specific to 
8oxoG.  We could then compare the RNA-Seq datasets to the 8oxoG-enriched 
datasets to see if we obtain similar conclusions. 
Many questions remain to be answered.  For example, do reactive oxygen 
species preferentially modify single-stranded RNA?  If so, we may observe fewer 
G>T mutations in structured regions versus unstructured regions.  We may also 
observe fewer G>T mutations in rRNA and tRNA compared to mRNA, assuming 
we are able to account for less coverage at these regions in our calculations 
since our libraries were depleted of rRNA and tRNA species.  In addition, we 
could examine whether certain motifs are prone to oxidation. Guanosines are 
highly susceptible to oxidation (Wurtmann and Wolin 2009), but in what context?  
Are runs of guanosines more susceptible than discontinuous guanosines?  Does 
the number of guanosines in a transcript correlate with the number of G>T 
mutations?  In-depth analysis may provide answers to some of these questions. 
Our ultimate goal was to investigate how cells deal with damaged RNA.  
Accumulating evidence suggests damaged RNA negatively affects translation, 
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with ribosomes stalling at the adduct (see Chapter I).  However, given the limited 
tools, we sought to develop a deep-sequencing approach to detect damaged 
RNA to see if we can gain additional insight into the relationship between 
damaged RNA and translation surveillance mechanisms.  For example, if 
translation-dependent quality control targets oxidized RNA, we would predict 
higher G>T mutations in coding regions (e.g. ORFs) versus noncoding regions 
(e.g. UTRs).  Moreover, we could test whether dom34∆, xrn1∆, rps31-211, or other 
strains deficient in quality control exhibit higher mutation rates compared to wild-
type yeast.  Additional insight could come from investigating ribosome dynamics.  
Our library preparation protocol can be easily adapted to other specialized 
sequencing.  Ribosome profiling would tell us whether G>T mutations appear in 
frame and, if so, at what codon position.  If ribosomes stall at 8oxoG sites, we 
could assess whether ribosome density positively correlates with G>T 
incidences.  Examining the relationship between G>T positions within the ORF 
and ribosome density might also tell us something about the stalling mechanism.  
For example, if ribosomes collide at 8oxoG sites, we may observe an increase in 
both G>T mutations and ribosome density toward the middle or end of ORFs.  
We could also generate 5'-phosphate sequencing libraries (5PSeq) from wild-
type yeast and yeast lacking XRN1.  5PSeq selectively sequences RNAs 
containing 5'-phosphates; the yeast cytoplasmic exonuclease Xrn1p generates 
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mRNAs with 5' phosphates, thus decay intermediates represent a major portion 
of reads.  5PSeq has allowed researchers to study ribosome dynamics during co-
translational mRNA decay (Pelechano et al. 2015).  By comparing mutation rates 
from each strain, we can determine whether 8oxoG RNAs are preferential targets 
for decay. 
Since 8oxoG is well-studied, appears under a variety of stressors, and is 
known to stall (or severely slow down) ribosome transit (Fiala et al. 1989; 
Nunoshiba and Demple 1993; Bruskov et al. 2002; Cadet et al. 2005; Shan et al. 
2007; Tanaka et al. 2007; Rada and Leto 2008; Wurtmann and Wolin 2009; 
Simms et al. 2014), we selected 8oxoG as a model lesion to develop our deep-
sequencing method.  Eventually, however, we would like to see if this method 
can be applied to other types of damage.  One would have to determine the 
conditions for RT read-through at specific adducts, such as pyrimidine dimers or 
platination.  Furthermore, the read-through of adducts does not necessarily lead 
to the insertion of a mutation.  For example, SuperScript™ II can read through 
bulky SHAPE adducts, but this usually manifests as deletions in deep-
sequencing data (Siegfried et al. 2014).  Nevertheless, once these conditions are 
established, subsequent analyses may uncover information regarding sequence 
features, ribosome dynamics, etc. for the adduct of interest.  Overall, our deep-
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sequencing approach may serve as the foundation for the study of other types of 
damaging adducts.
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